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Carbon nanotube arrays have been found to be highly effective at carrying out intracellular delivery of 
cargo at high efficiencies while ensuring cell viability. Template based chemical vapor deposition is a 
commonly used process to fabricate these arrays. However, current etching methods used to expose 
carbon nanotubes from templates are expensive and time consuming. The high cost and time-consuming 
processes currently required to fabricate such arrays are factors which limit the commercialization of this 
technology and inhibit scope for larger research programs.  In this thesis, alternative nanofabrication 
methods were explored with the aim of making the fabrication of CNT arrays cost effective and efficient. 
Mechanical polishing coupled with wet chemical etching is shown as a feasible alternative option to dry 
etching. The effects of process variables on physical properties of CNT arrays have been studied and 
quantified in order to demonstrate control over the process. Scanning Electron Microscopy has been used 
to qualitatively understand the differences between CNT arrays fabricated using dry etching and the 
alternative process. Cell culture has been demonstrated on the CNT arrays and the potential to use 3D 
printing to fabricate a nanofluidic device is also demonstrated. The alternative process can save etching 
time by 97% while maintaining a similar level of control over the process. This study therefore, opens the 
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According to the American Medical Association, the cause of more than 4000 serious diseases can be 
attributed to gene disorders [1]. These diseases include cancer, acquired immune deficiency syndrome 
(AIDS), cystic fibrosis, Parkinson’s and Alzheimer’s diseases. The cause may be gene mutations or 
missing genes caused due to external factors such as radiation, viruses or in many cases, mutations during 
deoxyribonucleic acid (DNA) replication. Most of these diseases are known to be incurable in the true 
sense of the word. Although there exist methodologies to slow down the spread of diseases like cancer 
and Parkinson’s, they are far from perfect, often resulting in harmful side effects and severely limiting the 
patient’s abilities and reducing quality of life.  
In the 1980’s, multiple studies were carried out 
on animal models to study the feasibility of 
transferring healthy genes into cells which upon 
expression in vivo would result in the 
development of healthy cells. This method of 
healing is known as gene therapy. It has in recent 
times been explored as a cure for cancer [2, 3], 
cystic fibrosis [4], HIV [5, 6] and color blindness 
[7] with highly encouraging results. The crux of gene therapy is to transfect stem cells with DNA or other 
proteins in vitro, depicted in Fig. 1.1. These cells, once genetically modified can repair, replace or inhibit 
the action of a specific DNA strand. The altered cells are then capable of developing immunity against 
attacking viruses causing the disease, express DNA which was earlier deficient to overcome a genetic 
disability or grow into enhanced macrophages which can further fight the disease in question. It can be 
concurred that the most important element of gene therapy is to develop a method for transfecting of cells 
with the DNA or protein in question without inducing harmful side effects and ensuring cell viability.  
 
Figure 1.1: Mechanism of gene therapy 
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Transfection into cells for gene therapy conventionally has been carried out using viral vectors or lipids 
[6, 8-12]. Viruses have the unique ability of expressing their genetics in the cells they infect. This ability 
of viruses has been taken advantage of by modifying viruses to express a desirable genetic code rather 
than a harmful one. However, side effects such as immunological attacks on viruses, homologous 
recombination and cytopathic effects must be considered when using viruses for transfection [10]. Other 
commonly methods of transfection being used include electroporation – the application of an electric field 
to cells allowing charged particles to move into cell [13, 14]; particle bombardment – bombardment of 
particles onto the cell membrane at high velocity with the intent of them breaking through the cell 
membrane [15]; and the use of micro needles and wires to inject into individual cells [16]. 
Each of these methods has been successful in transfecting cells with appreciable efficiency yet they pose 
multiple issues which are yet to be resolved:  
• Ensuring cell viability post transfection process 
• Controlling the amount of cargo delivered to cells 
• Cost effectiveness 
• Transfection into different cell types 
• Ensuring long expression times 
The above issues, most notably, ensuring cell viability post transfection process has been one of the 
biggest limiting factors for further expanding research in gene therapy and large-scale implementation of 
this technology. A number of researchers have explicitly expressed the importance of safer, more viable 
transfection technologies to accelerate research in gene therapy and for large scale applications [11, 12, 
17].  
  “The message we have extracted from a history of anticipation and disappointment is that the 
future success of gene therapy will be founded on a thorough understanding of vector biology and 
pharmacology (Kay et al, 2003).”  [10] 
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“The success of gene therapy is largely dependent on the development of a vector or vehicle that can 
selectively and efficiently deliver a gene to target cells with minimal toxicity (Li. et al, 2000)” [18] 
“we are still far from the perfect gene carrier suitable for clinical use (Niidome et al, 2002).”[15] 
In 2013, Golshadi et al [19]. were able to manufacture an ordered array of carbon nanotubes (CNTs) by 
carrying out template based chemical vapor deposition (TB-CVD) of anodized aluminum oxide (AAO) 
and applied it to nanofluidic transport applications. The CNT array thus developed consisted of highly 
ordered, vertical carbon nanotubes, open from both ends and supported by an AAO template. This CNT 
array showed encouraging results when utilized to transfect cells by culturing cells on the device [20], 
shown in fig. 1.2. Compared to current state of the art methods such as particle bombardment, 
electrochemical methods and micro-injections, CNT arrays are minimally intrusive, caused no damage to 
the cells and achieved higher transfection efficiency. This is a breakthrough invention for biologists and 
genetic engineers working on drug delivery, gene therapy, cell therapy and studying the effects of novel 
synthetic genetic material on cells. CNT arrays also present the advantage of being able to interface with 
multiple cells in parallel, allowing for injections at a larger scale compared to individual injections. 
CNT arrays offer the following advantages over current technologies: 
 
Figure 1.2: Schematic of CNT array device for intracellular delivery 
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• High transfection efficiency 
• Controlled volume of delivery 
• Cell viability 
• Ability to transfect multiple cells in vitro 
• Potential to transfect cells such as neural cells and stem cells 
A limiting factor for CNT array technology is the current fabrication procedure for CNT arrays. Being 
time consuming and requiring specialized processes is hindering large scale fabrication and exploration in 
further areas of research which can exploit CNT arrays to their full potential. In order to explore large 
scale manufacturing feasibility and bring down costs, it is important to study the fabrication methods 
available to make these devices and suggest potential improvements.  




Figure 1.3: Stepwise fabrication of carbon nanotube array 
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Annealing of template: The template used to manufacture the CNT device is an anodized aluminum oxide 
membrane (AAO membrane) which is 13mm in diameter and 60µm in thickness. The membranes are 
annealed prior to CVD to prevent distortion during the high temperature CVD process. 
Template based chemical vapor deposition: The membranes after annealing are ready for CVD. During 
CVD, the membranes are exposed to a continuous flow of ethylene in a sealed, high temperature furnace. 
The CVD set up used is depicted in fig. 1.4. Breakdown of ethylene leads to the deposition of carbon on 
the membrane surface and pores. The carbon deposited inside the pores of the membrane forms tubes. 
Carbon is deposited in its amorphous form and is not graphitic. 
 
Oxygen plasma etching: Before aluminum oxide can be etched away to expose tips of nanotubes, the 
layer of amorphous carbon deposited on the surface must be cleaned to expose aluminum oxide for 
etching. Oxygen plasma is used to selectively remove only the carbon layer and prepare the device for 
reactive ion etching.  
 
Figure 1.4: Schematic showing chemical vapor deposition (CVD) set up 
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Reactive ion etching using boron trichloride (BCl3): Reactive ion etching (RIE) is a combined physical 
and chemical etching method carried out in a weakly ionized plasma. BCl3 plasma is used to selectively 
etch aluminum oxide in a controlled manner. Etching is carried out to achieve an exposed length of 
~250nm of nanotubes.  
The device has demonstrated impeccable transfection into cells with minimal damage [20], however, 
there is scope for greater research such as studying the effects of variations in physical array dimensions 
on transfection, the method by which interfacing of device and cell occurs, transfection into a variety of 
cells and its application on tissue. These experiments require a large number of expendable CNT arrays. 
Also, the CNT arrays need to be produced quicker and with greater ease to make them feasible for large 
scale use in laboratories. 
fig 1.5. Shows graphically the time consumed in each manufacturing process. 
• The annealing process: Annealing takes up approximately 10 hours to anneal 10 membranes 
• The CVD process: The CVD process requires another 10 hours to coat 7 membranes 
• Oxygen plasma etching of amorphous carbon layer is a 20-minute process 
 
Figure 1.5: Breakdown of time required to fabricate CNT arrays 
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• Reactive ion etching using BCl3 is a 6 -12-hour long process which required specialized 
equipment and trained personnel to operate this equipment. BCl3 is also a highly toxic gas 
which is described as hazardous.  
Currently the process to fabricate these membranes can take up to 4 days for a batch size of 7 membranes. 
While the process can be scaled up using more sophisticated, large-scale equipment and parallel 
processing of batches, it is hindered by multiple issues which cannot easily be addressed.  
A dry etching process is also resource intensive. This hinders large scale economic production of these 
arrays since setting up of such equipment is extremely costly which makes the commercialization of these 
devices difficult.  
CVD and RIE processes, unlike conventional manufacturing processes are dependent on physical 
equipment variables such as size of chamber, voltage, power and position of substrate in the plasma 
chamber. A set of manufacturing parameters resulting in desirable outcomes on a certain set of equipment 
cannot be guaranteed to reproduce similar outcomes on a different set up. Equipment based variability is a 
major obstacle in ensuring repeatable results and preventing manufacturing errors. This is also a major 
obstacle in scaling up the current manufacturing system since a complete parametric study will be 
required with any type of equipment before it can be set up.  
This thesis explores alternative nano-fabrication processes to overcome the above-mentioned drawbacks 
associated with the current process. Ease of scale-up, control over physical dimensions of CNTs and ease 
of access were considered while exploring alternative fabrication processes. A combination of mechanical 
polishing and wet chemical etching is presented as a feasible alternative with the potential to reduce 
etching time from the range of 6-12 hours to 10-40 minutes. The process variables affecting CNT 
properties have also been studied and quantified in detail followed by a qualitative assessment of device 





2.1 Gene Therapy 
The method of gene therapy is gaining popularity in treating diseases which have a genetic background. 
According to the American Medical Association, more than 4000 diseases have their root causes in 
genetic mutations or alterations caused due to microbes [1], external factors such as radiation, 
environment or errors during reproduction. Gene therapy in its most basic forms aims to rectify the 
problem by delivering the missing or dysfunctional gene into a patient’s cells to allow for propagation of 
healthy cells and genetics.  
One of the most comprehensive definitions for gene therapy is given by the European Medical Agency: 
[21] 
“A gene therapy medicinal product is a biological medicinal product which fulfills the following two 
characteristics: (a) it contains an active substance which contains or consists of a recombinant nucleic 
acid used in or administered to human beings with a view to regulating, repairing, replacing, adding or 
deleting a genetic sequence; (b) its therapeutic, prophylactic or diagnostic effect relates directly to the 
recombinant nucleic acid sequence it contains, or to the product of genetic expression of this sequence. 
Gene therapy medicinal products shall not include vaccines against infectious products.”  
Gene therapy, as defined above, aims to deliver into cells the missing or deficient genes to enable 
expression of proteins which can act therapeutically against the disease in question. The most common 
mechanism employed in clinical trials around the world today is depicted in fig. 2.1 below: [22] 
Step 1: Blood cells or stem cells are extracted from the patient and incubated. Stem cells can differentiate 
into a variety of specialized cells and hence, they are preferred for gene therapy. Through injection of the 
missing genetic material, stem cells can be made to differentiate into healthy cells with the ability to fight 
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disease such as enhanced macrophages. In some cases, they are modified to prevent a certain microbe 
from entering the cell, as in the case of gene therapy for the human immunodeficiency virus (HIV). 
Step 2: The required cargo to be delivered is packaged inside a ‘vector’. The vector is a carrier with the 
ability to permeate the cell membrane and deliver cargo without damaging either cell or cargo. The vector 
should satisfy the following conditions: 
• Be able to permeate the cell membrane 
• Not induce any cytopathic effects in cells 
• Not induce homologous recombination 1 
• Be non-toxic 
• Should not initiate immunogenic response against itself 
• Be a safe carrier for cargo 
• Carry required amount of cargo 
                                                     
1 Exchange of nucleotides between similar DNA 
 
Figure 2.1: Process of gene therapy (A) using a viral vector (B) using non-viral vector 
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The most common vectors used for gene therapy have been viruses which were genetically modified from 
their original form to be non-toxic and satisfy to an extent the conditions listed above.   
Step 3: Cells collected from step 1 are infected with viruses modified in step 2 using techniques which 
will be briefly discussed in the next section. The viruses express the modified DNA they carried as cargo 
in the infected cell, leading to the creation of genetically modified cells. These cells upon division will 
now express the effects of the infected gene.  
Step 4: Injection of genetically modified cells back into the patient. The cells once injected into the 
patient will now follow instructions coded in the cargo delivered to them. This will allow cells to 
differentiate into specialized cells to fight diseases or produce proteins which can mitigate the effect of 
disease.  
2.1.1 Conventional Gene Transfection Technologies 
 
It can be seen from the above section that designing an efficient vector is one of the most critical elements 
of a gene therapy based healing process. In fact, the first trials of gene therapy were made possible only 
after Roger and Pfuderer [23] showed proof of concept for genetic transfer into mammalian cells using 
viruses. Ever since, viruses have been used as vectors for transduction in gene therapy clinical trials for a 
number of diseases such as cancer [2, 3, 24], HIV [6] and others [4, 25, 26].  
Viruses are microorganisms which are highly efficient in gaining access to cells and introducing viral 
DNA into their host cells. With this method, viruses are able to hijack the host cell into creating more 
copies of the virus. In the case of gene therapy, the ability of a virus to infect cells with its DNA is an 
advantageous capability. However, the viral DNA leading to toxicity and replication should be deleted 
and replaced by desirable cargo, depicted in fig. 2.2 before the virus can be allowed to infect the cell [27]. 
Sequences governing the functioning of the virus are left untouched but viral genes which lead to disease 




The viral vector particles also require purification which is often carried out using density gradient 
centrifugation. This step is often difficult to carry out and results in damage to the viral vectors, 
decreasing the number of viruses which can infect cells. Column chromatographic methods are also 
implemented and have overcome many drawbacks of centrifugation. [10] 
Some of the viruses commonly used in gene therapy are as follows: 
Lentiviral Vectors: Lentiviral vectors are derived from the HIV virus [27]. They have been used in gene 
therapy for the correction of β-thalassemia and X-linked [25, 28] adrenoleukodystrophy [29].  They have 
been used in earlier gene therapy trials owing to an ability to very well transcribe their ribonucleic acid 
(RNA) into cDNA2 of host cells which makes them good gene carriers into target cells [11]. However, 
lentiviruses and retroviruses still pose significant toxicity to the host cells. Lentiviral vectors were used in 
a gene therapy trial which was published in April 2000 to treat severe combined immunodeficiency 
(SCID)-XI disease. A leukemia like disorder in two of the patients was observed and led to much anxiety 
in the field of gene therapy. The retrovirus genome had inserted itself near a cancer-causing protein in the 
LIM domain3, activating its expression. [30] 
 
                                                     
2 Complementary DNA 
3 Structural protein domain playing important role in organ development, oncogenesis and cytoskeletal organisation 
 
Figure 2.2: Modification of virus to create a viral vector 
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Adenovirus Vectors: Adenoviruses are different from lentiviruses in the sense that they do not integrate 
into the genome of the cell [8], thus limiting the expression of their cargo to only limited number of cell 
generations before transduction is required again. Adenoviral vectors have also been popularly used for 
transfection in a number of clinical trials but have had their share of side effects. In 1999, 18 year old 
Jesse Gelsinger was part of a clinical trial at the University of Pennsylvania [31] aimed at treating 
ornithine transcarbylamase4 deficiency. This deficiency can cause an accumulation of ammonia in the 
bloodstream leading to an ammonium buildup in the brain which is a fatal condition. Gelsinger developed 
high fever within 4 hours after delivery of the viral vector and died 4 days later due to multi organ failure. 
The vector had accumulated in the spleen, lymph nodes and bone marrow, resulting in intravascular 
coagulation. Subsequent studies have shown that the adenovirus capsid protein can elicit an early 
inflammatory cytokine cascade.  
 It is thus shown that viral vectors pose a number of dangers to patients who take part in gene therapy 
such as eliciting immunological responses against viruses and destroying the vectors, inflammation, 
limited transduction capabilities such as being able to transduce non-dividing cells only, oncological 
effects, limited packaging capacity and others [32]. Viral vectors also present a challenge in terms of 
storage, handling and scaling up of operations for commercial use. It is of importance to develop a 
method of transfection which can achieve the same functionality without the above-mentioned side 
effects.  
To overcome these effects, the prospect of using non-viral vectors has caught up recently with a number 
of non-viral vectors being developed for use such as lipids, polymers, nanoparticles combined with 
physical means including injection, electroporation and gene gun [18] 
 
 
                                                     




Lipid refers to a class of special organic molecules, often fats, waxes, glycerides and oils that are soluble 
in water. In biological reference, lipids are the main constituent of the cell membrane. They are also used 
in the body as energy storage, signaling devices and to a lesser extent, for transportation.  
Lipofection is a lipid mediated method of transfection wherein a lipid-DNA complex is formed, ready to 
be accepted by the cell membrane. Often anionic molecules are bonded to positively charged lipids in 
order to maintain a net positive charge on the complex. The cell membrane accepts this complex since the 
membrane itself is a phosphobilipid layer with an overall negative charge. The anionic cell membrane and 
cationic lipid-DNA complex are attracted to each other and form lipoplexes due to electrostatic 
interactions. This leads the complex being taken up by the cell through endocytosis and the cargo 
subsequently being released inside the cell. 
This was first demonstrated in 1987 by Felgner et al [33] who used DOTMA for high efficiency gene 
transfer into kidney cells and fibroblasts. They demonstrated that 100% of the DNA was encapsulated by 
DOTMA in a 5:1 lipid to DNA ratio by weight. The transfection efficiency with varying concentrations of 
DNA and lipid was observed to be as high as 100% but a significant downside mentioned is that the 
DOTMA DNA complex would prove to be toxic beyond a certain concentration.  
Lipofectamine, manufactured by Invitrogen is one of the commercially available lipofection agents 
available and in widespread use. It is a cationic molecule which can form complexes with anionic nucleic 
acids. Although high transfection efficiencies have been observed using lipofectamine, it still poses toxic 
dangers to the cell. Madeira et al. [34] attempted transfection of green fluorescent protein (GFP) into 
human mesenchymal stem cells (MSCs) and observed up to 35% efficiency but noticed decreasing cell 
viability with an increased volume of lipid. Another drawback of using lipofection is that neutral cargo 





Microinjection can be viewed as a precursor to nanoscale devices. It refers to the physical injection of 
material into the cell by physically penetrating the cell membrane using a micro-sized injection device 
such as a needle or syringe. Fig. 2.3 shows microinjection into a single cell. The cargo to be delivered is 
coated on the needle which subsequently penetrates the cell membrane and delivers cargo inside the cell. 
Microinjection has widely been used in the creation of genetically modified animals such as pigs  [35] 
and expression of genes in mouse progeny by injection into mice eggs [36]. These are cases of small scale 
transfection where a limited number of cells were injected with the required gene. 
This method is victim to two major disadvantages: 
a. Low cell viability due to invasiveness of the method: A microinjection device has dimensions in 
the micrometer range which makes it invasive into the cell and reduces cell viability 
b. Limited throughput: Transfection done on a cell by cell basis is prohibitively slow. For gene 
therapy purposes, hundreds of thousands of cells need to be transfected. In such cases, 
microinjection is limited by its low throughput.  
 
   




An interesting, alternative use of microneedles or microneedle arrays is in the field of transdermal drug 
delivery. Drug delivery through hypodermic needles is often associated with pain and irritation, requiring 
specialized personnel for injection. Oral drug delivery is subject to reduced efficacy due to first pass 
metabolism in the body before the drug can reach its specified target. Microneedle arrays have been 
shown to be a potential candidate for alternative  drug delivery [16, 37-39]. They are associated with a 
lack of pain, reduced dosage due to increased drug efficacy and easy delivery to intended site through 
skin. These results are encouraging when it comes to applying carbon nanotube arrays for injection into 
tissue.  
Electroporation 
Electroporation is a method of transfection in which an electric field is applied across the cell [14], 
allowing it to take up charged DNA or other molecules which would under normal conditions not diffuse 
across the cell membrane.  
Under a short, high voltage electric field, phospholipid bilayers which are responsible for the integrity of 
cell membranes open, depicted in Fig. 2.4, allowing charged molecules to flow into the cell. These pores 
close immediately upon the removal of electric field. Electroporation has been found to work on a variety 
of cells and is also applicable for transfection in vivo, it does present a number of disadvantages which 
need to be overcome: 
• Collateral cell damage during electroporation is significantly higher. 
• Electroporation cannot permeate the cell nucleus. 
• The efficiency of electroporation depends on the electrical properties of cells being transfected. 
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• Limited control over the amount of material delivered into cells. 
 
Gene Gun (Particle Bombardment) 
 The gene gun utilizes high speed nanoparticles of heavy metals such as gold, platinum, titanium dioxide 
or polymers coated with the cargo [40, 41]. These nanoparticles upon impact with the cell are able to 
break through the cell membrane and thus deliver their cargo, shown in Fig. 2.5. The gene gun is effective 
in the transfection of hard to transfect cells such as plant cells but with the advent of more controlled 
methods, the use of particle bombardment has seen a decline. Some of the drawbacks of particle 
bombardment are as follows: 
• Ability of the targets to resist damage due to high speed particles 
• Little control over amount delivered into cells 
• Potential toxicity of nanoparticle carriers 
• Damage to cells 
 
Figure 2.4: Schematic of electroporation. Adapted from [77] 
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• Low efficiency (20-30% expression) 
The potential to overcome the above limitations set forth by viral and non-viral vectors can be explored 
using injection devices which have been designed specifically to inject into cells with high efficiency 
without damaging the cell membrane. Work in the field of nanotubes, nanowires and their arrays has shown 
that these devices are capable of achieving transfection into cells. Researchers have different approaches 
for transfection with these structures. A common approach is to use high aspect ratio nano-needles or pillars 
with a height ranging from 2-6µm and a tip diameter in the tens of nanometers. Cargo is usually coated on 
the surface of these pillars with the help of an amphiphilic coating [42, 43] and then delivered into the cell 
when the needle or pillar penetrates the cell membrane by physically breaking through it. The cells might 
penetrate the device under their own weight or in some cases, physical pressing or centrifugation [44] is 
utilized to accelerate the process. Results from selected previous works are presented below. 
3.1.2 Nano Structures for Transfection 
In 2007, Kim et al [43]. prepared Si nanowire arrays with the intent of physically transferring material 
into the cell by rupturing the cell membrane using nanowires. The nanowires were 90nm in diameter and 
60m in length. Human Embryonic Kidney Cells (HEK293T) were grown on the clusters of nanowires 
which seemed to penetrate the cell easily without any external force. Cargo was coated on the Si nanowire 
 
Figure 2.5: Process of particle bombardment 
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array and delivered into the cell through physical piercing of the cell membrane. This required 
functionalizing the nanowires to bind cargo. The nanowire arrays were fabricated using gold 
nanoparticles seeds planted on Si (111) wafers subject to CVD. The Si needle diameters were controlled 
via etching in HF after oxidation. This was one of the earliest transfection attempts using Si nanowires. 
Cell viability was observed at 78% with cells surviving a maximum of 3 days (Mouse embryonic stem 
cells). Primary attempts at transfection were carried out on HEK293 cells with DNA electrostatically 
attached to SiNWs. An efficiency of less than 1% was observed but this was attributed to the strong 
bonding between SiNW and DNA. 
In 2009, Shalek et al [42] were able to manufacture vertical SiNW arrays for transfection into cells with 
the difference being mainly in the dimensions of nanowires. Although not explicitly reported, the SEM 
micrographs convey wire lengths of 1m and diameter in the 50nm range. They used a similar 
manufacturing method as Kim et. al. Transfection was attempted using multiple cell types such as HeLa, 
human fibroblasts and rat hippocampal neurons. Regardless of the type of cells used, they claim to have 
observed a 95% transfection efficiency in all cells within 1 hour. They also utilized surface 




 VanDersarl et al. in 2012 [45] developed silicon ‘nanostraws’ for direct fluidic access into cells. The 
nanostraws were hollow, 100nm in diameter and 1m in height. Poly-carbonate membranes were used as 
templates for aluminum oxide deposition. Alumina specific reactive ion etch followed by a poly-
carbonate specific etch were used to expose nanostraws. They used membrane impermeable dyes to 
demonstrate transfection and observed 3-10% transfection rate of the cells pierced by the nanostraws. 
Array devices fabricated by various researchers are shown in Fig. 2.6. 
The above are examples of using devices in the microscale for cell transfection. It is observed that even 
though extremely high aspect ratio devices do facilitate transfection, the efficiency of transfection and cell 
viability observed has been generally low (Table 1) and not feasible when compared to traditional 
methods such as lipofection or electroporation. The fact that these methods rely on puncturing the cell 
membrane to physically interface with it begs greater study on whether a tight seal is formed around the 
cell – structure interface or contents of the cell are in danger of leaking out. Smaller structures or a lower 
aspect ratio, such as the carbon nano syringe array developed in 2008 by Park et al [46] have been shown 
to exhibit higher transfection efficiencies. The carbon nano syringe arrays were fabricated with a diameter 
 
Figure 2.6: Devices fabricated by other researchers (A, B) Nanowires by Kim et al [43] (C, D) 
Silicon nanostraws by VanDersarl et. al [45] (E, F) Silicon nanowire arrays by Shalek et al [42], 




of 50nm and heights of 80 and 120nm using TB-CVD process followed by ion milling and wet etching, 
which is a method very similar to the one employed by Golshadi et al. However, nano syringe arrays 
differ in the fact that they only have one open end, thus requiring preloaded cargo inside tubes before 
cells can be seeded on them. They were able to achieve 85% cell viability compared to the control and 
37% overall gene expression. Golshadi et al. [20] demonstrated transfection using carbon nanotube array 
on HEK293 cells with propidium iodide (PI). They confirmed 98% cell viability using flow cytometry 
and observed 99% transfection within viable cells. This study shows us that carbon nanotube arrays with 
a lower aspect ratio are a more feasible method to transfect cells. Hence, in this study, we focus on the 
low cost fabrication of a device similar to the one developed by Golshadi et al.  
Device Type Cell Transfected Cargo Viabil
ity 
Efficiency 
Kim et al.  6µm tall wires, 
90nm tip 
diameter 
HEK293 DNA-GFP -  <1% 




NIH3T3 Cells pEGFP 85% 30% 




CHO cells Plasmid DNA 
(pGreenLantern-1) 
 
-  <1 % 












Table 1: Comparison between array devices developed for transfection 
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Irrespective of the results obtained, we can observe that most devices developed required forms of 
reactive ion etching, silicon microfrabrication techniques or other methods which can hinder their large-
scale development either due to lack of equipment availability or prohibitive costs. We thus wish to 
explore a low cost; high throughput manufacturing technique will make these devices available to 
researchers in need of such technology en masse.  
Another advantage of carbon nanotube based devices is the possibility of adding multifunctional 
capabilities through functionalization to convert them into sensors while being able to transfect into cells. 
Section 3.3.1 mentions the applications of carbon nanotubes for sensing through chemical 
functionalization. 
2.2. Carbon Nanotubes – Properties and Applications 
Carbon nanotubes are a unique fullerene type allotrope carbon. They can be in the form of ordered, rolled 
up sheets of graphene or have an amorphous crystal structure depending upon their manufacturing 
technique. Carbon nanotubes, due to their varied atomic arrangements, exhibit mechanical, optical and 
electronic properties which can vary across a large spectrum. This also makes them useful for a wide variety 
of nanobiological applications such as tissue engineering, drug delivery, in vivo sensing applications, gene 












Atomic Structure of CNTs 
Carbon nanotubes are classified as shown in Fig. 2.7: 
 
 
Amorphous CNTs have no long-range crystal structure and are basically amorphous carbon in a tubular 
shape. Graphitic CNTs are further classified as single walled nanotube (SWNT), multiwall nanotube 
(MWNT), double wall nanotube (DWNT). They can be visualized as rolled up sheets of graphene. SWNTs 
are a single tube while DWNT and MWNTs are visualized as concentric, multiple tubes. DWNTs are often 
classified as a separate category from MWNTs since they can be obtained with high purity. MWNT samples 
often have SWNTs present and vice versa. SWNTs have a diameter of 3-7nm while MWNTs can be up to 
25nm in diameter. The lengths of CNTs have been observed in the order of microns. During template based 
CVD, the dimensions of CNTs produced depend upon the template used.  
The structure of graphitic CNTs can be described by the ‘Chiral Vector’ for CNTs made out of rolled 
graphene sheets. In Fig. 2.8, the chiral vector is made of the components ma 1 and na 2 with a 1 lying across 





Figure 2.7: Classification of carbon nanotubes 
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all hexagons in half. The 
wrapping angle is defined at the 
angle between the chiral vector 
and arm chair vector. If ɸ=0, the 
tube is known as an armchair 
tube, if ɸ=30, it is a zigzag type 
and for 0<ɸ<30, it is a chiral tube. 
The values of m and n describe the 
chirality of the tubes and also its 
diameter. The chirality can be 
used to deduce the mechanical, 
electrical and optical properties of 
a nanotube. A single walled 
nanotube will exhibit conductive properties if n-m is a multiple of 3 and otherwise semiconducting. Carbon 
nanotubes have also been fabricated in an amorphous carbon form by multiple researchers. Carbon 
nanotubes formed after CVD are usually in the amorphous form since graphitization of carbon requires 
temperatures above 1200°C. Amorphous nanotubes differ from their graphitic counterparts in having lower 
electrical and thermal conductivity. The physical properties of amorphous tubes cannot be controlled by 
adjusting parameters such as chirality. However, for our application, amorphous nanotubes are easier to 
manufacture due to the lower CVD temperature and time needed. Dimensions of amorphous carbon 
nanotubes can be controlled by changing the template dimensions, leading to easy control of size over the 
resulting tubes.  
 
 
Figure 2.8: Chirality of graphitic carbon nanotube [78] 
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2.2.1. In Composite Materials 
Mechanical studies on CNTs have shown them to be the strongest materials known to mankind. They also 
possess an extremely high young’s modulus. This makes CNTs especially attractive in structural 
applications. Lau et al [47] have demonstrated the use of CNTs in epoxy composites. They observed that 
despite their high strength and stiffness, CNTs did not offer satisfactory interfacial bonding at the CNT-
epoxy interface. This work was further supplemented by Kim et al. who used surface modifications to 
improve interfacial bonding and showed the feasibility of using CNTs in epoxy composites. Nano-
biological applications of carbon nanotubes can greatly benefit from the high strength of carbon 
nanotubes in applications pertaining to cellular injections using CNT probes. Also, since cells can be of 
varying mass and sizes, stronger structures minimized the risk of yielding or breakage of tubes inside 
cells or within the extracellular matrix, eliminating chances of cytotoxicity. 
CNTs can also be looked at as the most idealized and defect free form of carbon fiber, with mechanical 
properties close to theoretically predicted values of properties for carbon fiber. Gojny et al. showed that 
even an addition of 0.1 wt.% CNTs in epoxy to led to an increase in Young’s modulus from 3.29 to 3.50 
GPa. [48] 
3.2.2 In Electronics: 
As consumer electronics continue to shrink with more functionality being added to smaller circuits, CNTs 
are looked up to replace metallic wires which cannot be shrunk down to the nano-scale. From an 
electronics point of view, nanotubes offer the following advantages: 
· Conventional metals and semiconductors have in their lattice structures multiple defects, holes 
and dangling bonds. This leads to collisions and scattering of charge carriers which in turn 
produces heat and reduces the maximum current density that can be carried by the conductors. 
Carbon nanotubes possess near perfect structures with all chemical bonds satisfied, this implies 
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that conduction is possible with lesser heat dissipation and at maximum current density of 109 
A/cm2 compared to 104 A/cm2 for metallic conductors [49] 
· CNTs have high mechanical and thermal stability. This is due to the strong covalent bonding 
between carbon atoms. 
· They can be made to behave as both metals and semiconductors depending upon their atomic 
arrangement. This property of CNTs can be utilized to make complete electronic circuits with 
both transistors and interconnects using only nanotubes.  
High conductivity and small size makes carbon nanotubes worthy of use in cellular electrochemistry, 
further enhancing their use as sensors and adding multifunctional capabilities to them.  
Nanoscale field effect transistors and gates have been developed using SWCNTs. It has been shown that 
CNTFETs even at a nascent stage of development are competitive compared to the current state of the art 
technology available.  IBM expects nano electronics to be realized within this decade as an alternative to 
silicon microstructures. CNT are also being looked into for use in Li-ion batteries and fuel cells [50-52]. 
They have a high surface area to volume ratio, offer more intercalation sites in the form of interstitial 
spaces and tube cavities. CNTs also have an affinity for hydrogen adsorption which makes them a 
potential candidate for use in fuel cells and replace traditional platinum catalysts. 
2.3 Carbon Nanotubes in Nano-Biotechnology applications 
Unique and flexible mechanical, chemical, optical and fluid transport properties have found CNTs a 
prominent spot in biomedical research. 
The use of carbon nanotubes in biomedical applications includes using them as drug carriers [53, 54], for 
transfection of DNA and proteins into cells [46], miniature biosensors with high selectivity and 
sensitivity, targeted enzyme delivery, cell tracking and labelling, building of tissue matrices and as 
imaging contrast agents. [49, 55, 56] 
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2.3.1 Bio sensing 
The nano-dimensions of CNTs make them suitable for interacting with individual cells. The possibility of 
being able to monitor cell behavior, analyzing cell chemistry, ion transport, enzyme behavior and 
secretions will be advantageous in comprehending many mysteries of drug behavior, physiological 
responses at the larger scale and identifying disorders or unnatural behavior with greater accuracy. 
Wang et al [57] have been at the forefront of exploring the use of CNTs as biosensors. They have shown 
the applications of CNT/Teflon composite electrodes in detecting hydrogen peroxide and NADH. 
Experiments also showed favorable response of the electrolyte over the complete potential range. The 
CNT/Teflon electrode also responds very rapidly to changes in the level of hydrogen peroxide and NADH 
and low noise levels. Wang et al also developed the first sensor with a CNT based electrode for 
amperometric and voltammetric determination of insulin. They observed increased electron transfer 
kinetics using CNTs. 
In another study, Li et al [58]. were able to fabricate a CNT array embedded in SiO2 for ultrasensitive 
DNA detection and were able to detect lower than a few attamoles of oligonucleotide targets. These 
applications using carbon nanotubes provide encouraging results to utilize CNT arrays as multifunctional 
devices for sensing, while at the same time behaving as drug delivery or transfection vectors. 
2.3.2 Cell tracking, labelling 
With the advent of artificial tissue constructs, it becomes important to be able to analyze the progress of 
tissue growth in-vivo and visualize cell migration, cell multiplication. This needs to be carried out with 
minimal intrusion to prevent external factors from influencing results. Conventional methods such as flow 
cytometry or fluorescence microscopy are either complex and time intensive methods [59]. CNTs can 
provide an alternative to these methods. Cherukuri et al [60] demonstrated the use of SWCNTs in optical 
labelling. Excitation of SWCNTs dispersed in a pluorinc surfactant incubated with mouse peritoneal 
macrophage-like cells resulted in a structured fluorescence spectrum. In vivo optical imaging is often 
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hampered due to tissues that absorb light, narrow optical absorption and broad emissions. CNTs possess 
optical transitions in the near infrared range which allows for greater penetration owing to lesser 
absorption. 
Nanotubes were also observed to have remained in cells after repeated cell divisions. This observation 
encourages the application of CNTs in studying cell divisions and stem cell differentiation. 
2.3.3 Imaging Contrast Agents and Radiotracers 
Carbon nanotubes being composed purely of carbon provide poor contrast in MRI. This is overcome by 
taking advantage of their ability to be functionalized. Heavy atoms such as gadolinium can be attached to 
the surface of the tubes or caged inside them. The ‘Gadonanotubes’ thus produced displayed proton 
relaxivities 40 times above Gd[(DTPA)(H2o)]-2 which is a standard clinical contrast agent. 
Singh et al. [61] were able to demonstrate the in vivo biocompatibility of CNTs by functionalizing them 
with radiotracers and studying their movement through the bloodstream. Indium (111In) was covalently 
bound to SWNTs and administered to mice. The CNTs did not show a tendency to accumulate in a certain 
organ and were cleared from the blood via renal excretion. They could also be visually observed in urine. 
No mortality or toxic side effects were noted. This showed that CNTs can be used in vivo without 
eliciting harmful side effects in the bloodstream and are excreted. 
2.3.4 Tissue Engineering 
Regenerative medicine is a method of healing that involves rebuilding damaged organs and body parts 
using stem cells or genetic modifications. Cells when grouped together create around themselves their 
own supporting structure called the extra cellular matrix or tissue scaffold which acts as a medium for 
signaling molecules between cells. Through proper understanding of the requirements of cells and tissues, 
there exists scope to modify or rebuild damaged tissues. [55, 62, 63] 
CNTs have simplified methods to track cells, understand development of the tissue and study its viability. 
Optical labelling of cells carried out using functionalized CNTs which easily permeate the cell membrane 
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has the potential to track cells without using expensive, complex methods such as flow cytometry or 
intravital microscopy. CNTs do not require specialized equipment or extraction of cells from the body to 
detect cells but can be used in vivo. The chemical functionalization of CNTs can be carried out using 
chemical methods only which greatly simplifies the process. CNTs with functional groups attached to 
them can be detected by Raman spectroscopy [53]. When inside a tissue matrix, the chemical changes in 
functional groups can be used to study microenvironments around the cell. 
Implantable biosensors which can relay information in real time about vital tissue parameters such as pH 
and glucose levels are also being explored [57, 64]. With a high surface area to volume ratio, the active 
area available for analysis is large, which allows for higher sensitivity. Since CNT array devices can 
interface with a number of cells in parallel, with the proper functionalization, they have the potential to 
monitor a large number of cells in vivo and provide substantial amounts of data regarding cell behavior.  
Another area of interest is the use of CNTs as structural support for tissue matrix [55, 63, 65]. The matrix 
is a critical component of tissues and greatly affects its development. Conventional matrix materials are 
usually synthetic polymers such as PLA, which lack the required mechanical strength.  CNTs dispersed in 
chitosan, a biopolymer, showed improved mechanical properties. 
Gene Transfection 
Carbon nanotube arrays have been used to achieve transfection into cells of different kinds. Park et al. 
demonstrated transfection into fibroblast cells with up to 35% efficiency. Golshadi et al. demonstrated 
transfection into HEK293 and were able to achieve 99% transfection in live cells. Carbon nanotube arrays 
have also demonstrated the ability to transfect dye, DNA and quantum dots into cells, proving that they 
can be used in a versatile manner.  
2.4 Fabrication 
The success of carbon nanotube devices is in part contingent upon their ease of fabrication and 
accessibility. It was observed earlier that most array devices are manufactured using techniques which 
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cannot easily be adapted to commercial scale fabrication with reasonable costs. In order to develop a 
more feasible nanofabrication method, it becomes important to look at viable alternative techniques used 
in micro-nano fabrication. Given the variety of applications requiring the use of CNTs, researchers have 
formulated novel methods to fabricate them and control their physical dimensions. Some of the most 
prominent ones are mentioned below.  
2.4.1 Chemical vapor deposition 
Chemical vapor deposition is a method of applying thin film coatings to materials and also to produce 
high purity bulk materials. 
It requires flowing a precursor gas over the heated object to be coated. High temperatures are maintained 
by keeping the target item in a furnace. As the precursor gas flows over the target material, chemical 
reactions occurring over it result in the deposition of a thin film on the surface. CVD provides multiple 
advantages over other deposition processes such sputtering or physical vapor deposition. 
Because precursor gases used in the processes can be obtained in very high purities, the deposited 
material is devoid of contaminations, making CVD one of the most reliable methods to obtain a pure film. 
The gaseous nature of active material means that all crevices, pores and open surfaces are deposited with 
an even and continuous layer of film without breaks or large variations in thickness. It is also one of the 
few methods which can deposit material films with nanoscale precision.  
Apart from obtaining controlled and pure film depositions, CVD equipment and set ups are easier to use 
and operate. Unlike sputtering, there is no line of sight requirement for CVD, as long as the precursor can 
access the object to be coated. Regular CVD works without the requirement of plasma, ions or lasers but 
these methods are often employed for specialized applications to improve yield or reduce time for CVD.  
Depending upon the application, substrate requirement, material to be deposited, cost, precursors and 
deposition requirement, different kinds of CVD reactors are available. 
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1. Hot wall Reactor: These represent the more common and less complex CVD systems. They essentially 
consist of a chamber containing the target substrate, with the chamber surrounded by a heat source. Walls 
of the chamber are not cooled but heated by the heat source, thus the name ‘Hot Wall Reactor’. The 
chamber can be of different sizes depending upon the number of parts to be held, with shelves or might be 
as simple as a ceramic tube. Temperatures in these reactors are usually very high, limiting factor being the 
materials used in the process or construction of reactor. Their advantages include being able to maintain 
uniform temperatures resulting in even film thicknesses. On the downside, due to a heated chamber walls, 
some deposition occurs on the walls of the chamber and gas inlets or exhausts, requiring frequent 
cleaning. This may also lead to higher energy and precursor requirements. The CVD process used by 
Golshadi et al. utilizes a hot wall reactor due to ease of use, even thickness of deposited film and 
availability.  
2. Cold wall reactor: These are another major category of CVD reactors. In this type, the chamber walls are 
cooled by running coolant through them and only the substrate holder is allowed to heat up. The holder 
may be heated using resistance heaters, induction or lamp heated. They are often used in high pressure 
applications with more reactive precursors. Although they present the advantages of reduced deposition 
on walls and lower thermal loads on substrate due to faster heat up and cool down times and consequently 
lower energy consumption, they do present more complicated disadvantages which requires careful 
process monitoring. 
· Non-uniform temperature distribution on the substrate, leading to non-uniform film thicknesses 
· Thermal stresses in case of quick heating and cooling 
· Smaller batch sizes compared to hot wall reactors 
The use of TB CVD to grow nanotubes was first shown by Che et al in 1997 [66]. They showed that 
CNTs could be grown inside AAO membranes and develop into highly ordered arrays. Precursors used in 
the process were ethylene and pyrene. They also demonstrated the use of catalysts such as Ni, Fe and Co 
upon the CVD process and resulting nanotubes. 
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The compatibility of the nanotubes thus produced was not tested on biological systems since their primary 
focus was on applying them to the anode of a Li-ion battery. They observed that carbon nanotubes inside 
formed using ethylene as a precursor on Ni catalyzed AAO membranes were ordered and formed without 
any macroscopic defects. It is also observed that further exposure to higher temperatures after CVD 
converts the atomic structure of amorphous CNTs to ordered graphite. 
Fe and Co were also explored as catalysts with ethylene as a precursor as 580°C for 30 minutes. In the Co 
catalyzed membranes, CNT structures were formed but were not ordered or symmetric and fused 
together. Fe catalyzed membranes did not show any sign of CNTs in them. 
This study provides important insights for increasing the rate of CVD and possibly shortening fabrication 
times. The observation that CNTs thus formed were conductive motivated the idea of applying them as 
sensors.  
Xu et al. [67] also demonstrate the growth of carbon nanotubes on AAO membranes while using cobalt as 
a catalyst. They different from the devices manufactured by Che et al. since their CNTs grew out of the 
membranes onto its surface. They go a step ahead to show how CNTs produced can be modified to 
eliminate the effects of the catalyst on their applications by using ultrasonification to chop off the excess 
CNT lengths from above the membrane. The AAO membranes utilized by them had an average pore 
diameter of 60 nm and interpore spacing of 100nm. Co was deposited using electrodeposition and CNTs 
grown using CVD with ethylene as a precursor at 650°C. Etching of AAO membrane was carried out 
using an aqueous mixture solution of CuCl2 and HCl 
TB-CVD is thus a well-established method for fabrication of nanotubes with different sizes and for a 
variety of applications. The use of a hot wall reactor is selected for this study due to availability, uniform 
film deposition thickness and ease of use.  
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2.4.2 Etching technologies 
Wet Etching 
Alumina is an amphoteric oxide which can react well with both acids and bases. It has been established in 
a number  of studies  that AAO can be fully dissolved using dilute NaOH, H3PO4  and HF. Researchers 
have commonly used NaOH to release CNTs formed using TB CVD to release CNTs from the template 
[68-70].  
The following reactions take place when AAO reacts with an acid or base: 
2OH-  + Al2O3    2AlO2
- + H2O 
6H+   +  Al2O3    2Al 
3+ + 3H2O 
There have been multiple studies carried out on wet etching of AAO membranes [68, 70-73]. The most 
common etchants include NaOH, H3PO4, Hu. et al [70] have investigated the etching of AAO with H3PO4 
and NaOH and reported linear mass dissolution rates for both. NaOH is also reported to be a stronger 
etchant whereas the slower etch rate of H3PO4 makes it more suitable for exposing nanotubes due to better 
control over exposed lengths. Golshadi et al. also carried out studies using wet etching with varied 
concentrations and reported similar trends as Hu et al. They also observed a decrease in etch rate with 
temperature.  Lee et al. [74] who used AAO as a template to create gold tipped nano arrays also utilized 
wet etching to eliminate the AAO template. They utilized a mixture of H3PO4 (6wt%) and Cr2O3 
(1.8%wt) at 60°C for 1 day.  
 
Dry Etching 
Dry etching is commonly used in microfabrication to selectively remove material. In template based 
manufacturing of array devices, dry etching has been used to selectively etch the template and expose 
carbon nanotubes from template [20, 75]. Dry etching can be both reactive and non-reactive. Material 
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removal achieved by exposing material to highly energized plasma. Plasma of reactive gases such as 
boron trichloride, oxygen and fluorocarbons might be used to achieve a combined reactive and physical 
etching mechanism, known as reactive ion etching (RIE). In other cases, non-reactive, heavy gases such 
as argon or gallium are used to achieve a purely physical etching, called sputtering or ion milling.  
Mechanism of dry etching 
A dry etching set up typically looks like the one shown in Fig. 2.9. The plasma chamber is a sealed, 
vacuum chamber with electrodes on the top and bottom. The lower electrode is where a sample to be 
etched is placed. It is connected to an RF power supply and a blocking capacitor. When the process is 
started, a vacuum pump evacuates the chamber down to low pressures (~5 MPa) and allows the required 
etching gas to flow into the chamber. An alternating electric field is set up inside the chamber using the 
RF supply. The most commonly used frequency for the electric field is 13.56MHz. At this time, electrons 
being lighter, move with the electric field. During this rapid movement, they strike other atoms with high 
energy which is usually higher than the ionization energy leading to either excitement of electrons in the 
atoms or ejection of electrons, which leads to formation of more ions. As the population of electron 
grows, cascade reactions take place which results in the formation of more and more ions. The plasma 
formed in a reactive ion etching chamber is a weakly ionized plasma, also known as a glow discharge 
plasma. An important characteristic of the glow discharge plasma is lack of thermal equilibrium between 








Where k is the Boltzmann’s constant. Thus 𝑇𝑒 >> 𝑇𝑔, and the gas remains at approximately room 
temperature. Because glow discharge plasma is a weak plasma, the number of electrons is lesser than the 
number of ions, keeping the chamber at room temperature. The lower electrode upon which sample is 
placed experiences a negative DC bias due to the presence of a capacitor. This leads to repulsion of 
electrons from the region near the lower electrode. Since no electron-ion interactions take place here, this 
area is referred to as the dark region. As positive ions approach this region, they are accelerated due to the 
local negative potential created at the lower electrode. These ions gain energy and are responsible for the 
directional etching profiles obtained through dry etching. In our case, this process is able to uniformly 
etch away the AAO membrane, leaving behind a smooth surface with no debris. 
Ion Milling 
Ion milling is a non-reactive method of dry etching and can be used to etch away the template in template 
based fabrication techniques. It is not material specific, since the mechanism of dry etching is purely 
physical. Unlike focused ion beam (FIB) milling or electron beam milling, ion milling is used for material 
 
Figure 2.9: Mechanism of dry etching 
45 
 
removal over larger surface areas without specific targeting. Ion milling is a form of dry etching 
characterized by the use of inert gases for etching. Most dry etching processes are some form of reactive 
ion etching processes which involve chemical and well as physical interaction between ions and sample 
material. The chemical reactions aid in etching, thereby accelerating the etch rate. However, the gases 
used in reactive ion etching such as boron trichloride and carbon tetrafluoride are toxic and hazardous. 
These gases require special handling considerations while at the same time etch much slower compared to 
wet etchants such as NaOH or phosphoric acid. 
Ion milling relies purely on the physical interaction between ions and the sample for material removal. In 
its simplest form, it can be thought of as a method of ‘sandblasting using ions’. Energy transferred from 
ions to atoms of the surface of the material allows atoms at the surface to gain enough energy to break 
away from the crystal structure, resulting in material ablation. A lower pressure allows more ions to 
impact the surface since the mean free path is inversely proportional to the ambient pressure. This also 
decreases scattering of ions thus leading to a more directional etching profile, making ion milling 
applicable to a variety of materials without much variation in etch rate. Milling using argon is inexpensive 
and simple to carry out. 
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Figure 2.10: Schematic representation of a cross section view for the Whatman Anodisc AAO membrane 
(A) Magnified cross section view of template with dimensions. Dotted line indicates end of lattice layer (B) 





Fig. 2.10 is a schematic showing the cross section view of AAO membranes used as templates. These 
membranes consist of ordered pores which run the entire thickness of the membrane and open at both 
ends. Pore diameter at the top is close to 200nm and 250nm at the bottom surface. The top is also 
characterized by presence of a mesh like AAO layer we call ‘lattice structure’. This lattice structure 
hinders direct access to the pores and is non-functional for our use. During etching, considerable time is 
spent in removing this lattice layer since ordered carbon nanotubes are not found in this region. The 
required length of nanotube exposure is only ~200nm but time spent in clearing away this layer slows the 
fabrication process. Removal of this layer prior to manufacturing is desirable because not only will it 
reduce etching but potentially improve the quality of the array fabricated using wet etching. The use of 
ion milling, wet etching and mechanical polishing are prospective methods of removing the lattice. 
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3. Selection of Alternative Nanofabrication Process 
In order to reduce fabrication time and increase yield, it became important to study and evaluate a number 
of fabrication processes which could replace the current process. This chapter discusses the process of 
selecting a feasible alternative nanomanufacturing method. Fig. 3.1 below shows the alternative processes 
that were proposed to replace current methods. 
 
Figure 3.2: SEM micrograph of array after etching with 1M NaOH for 6 minutes. Tubes 
can be seen embedded inside pores (circled). (A) Normal view (B) 35̊ tilt view. Scale bar 
500nm 
 




3.1 Wet Etching 
Reactive ion etching, being the most expensive and time-consuming process, was of highest priority in 
elimination. The wet etching of Aluminum oxide can be carried out by using easily obtainable compounds 
such as sodium hydroxide and phosphoric acid. These compounds also present the advantage of easy 
disposal and relatively safe handling. This makes wet etching a promising alternative to reactive ion 
etching. Initial trials were carried out for the above process using O2 plasma followed by etching in 1M 
NaOH.  
 
Figure 3.3: SEM micrograph of array after etching with 1M NaOH for 20 minutes. 
Tubes can be seen coalesced together. (A) 35o tilt view (B) Normal view. Scale 
bar (A) 500nm (B) 1µm 
 
 
Figure. 3.4:  Schematic showing the progression of wet etching 
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It was observed that despite the rapid speed of etching, its isotropic nature leads to a condition referred to 
as pore widening. In Fig 3.2, we observe that after 6 minutes of etching the CNT array, part of the lattice 
layer remains, covering the tubes. Tubes can be seen within the pores but they have not been exposed. At 
20 minutes of etching, tubes are very clearly exposed however, the template has been excessively etched 
and the thinner sections of AAO separating the pores have also been dissolved in the NaOH. This is 
illustrated in Fig. 3.3 above. The lack of support resulted in CNTs collapsing upon one another and 
forming a coalesced clump instead of an ordered array, depicted in Fig. 3.4. Another observation critical 
to our application was the formation of towers on the surface which implied that etching was not evenly 
carried out.  
Based upon the above results, the following conclusions were drawn 
1. In a short timeframe, wet etching is sufficient to expose a limited number of tubes. But, the lattice 
structure will remain dominant with random peaks across the surface. With extended duration of 
etching, pore widening becomes the dominant feature, this leads to a loss of support for the 
nanotubes and eventual clumping together, most likely due to the surface tension of etchant.  
2. If the lattice layer can be removed prior to etching the CNT arrays or prior to beginning the 
fabrication process, wet etching can potentially expose the required length of CNTs in a short 
amount of time without pore widening.  
From the above conclusions, it could be inferred that a method to eliminate the lattice layer would be 


















Figure 3.5: Removing lattice layer before etching 
 
Figure 3.6: SEM micrograph of bare AAO membrane after wet etching for 7 minutes in 1M 
NaOH (A) top down view, arrows showing pores under partially etched lattice (B) 35 tilt view 
showing pillars. Scale bar 1µm 
52 
 
Figure 3.5 depicts the fabrication process proposed, involving the removal of lattice layer. The lattice 
layer could be removed after the CVD process or prior to it. The first attempt was carried out using NaOH 
to etch away the lattice from a bare AAO membrane. The images in Fig. 3.6 show that compared to an 
unetched membrane, there is a significant reduction in the lattice, however, the presence of pillars is 
observed. Since a smooth surface is required for the exposure of coplanar CNTs, alternative methods 
were considered.  
3.2 Ion Milling 
A potential method to eliminate the lattice layer was to utilize ion milling. Initial studies carried out using 
ion milling have provided proof of concept and encouraging results for removing the lattice layer. As 
mentioned in Sec 2.4.2, the process of dry etching for AAO is not well documented. A method of wet 
etching (referred to as the drop method) followed by dry etching was studied to observe the prospects of 
using a hybrid method. This involved placing a small amount of etchant (in this case 1M NaOH) upon the 
membrane to form a drop as shown in Fig. 3.7. It was done so to minimize etching from the bulk of the 
template by reducing the rate of replenishment for available etchant in the pores. This sample was later 
exposed to ion milling.  
SAMCO RIE 1C, benchtop 
reactive ion etching machine 
was used to carry out all ion 
milling procedures. Ion milling 
with multiple conditions was 





Figure 3.7: Utilization of minimal etchant or ‘drop method’. This is 





 Temperature Power Flow Rate Pressure 
Case 1 25ᵒC  100 W 45 SCCM 31.45 Pa 
Case 2 25ᵒC 200 W 10 SCCM 12.97 Pa 
Case 3 25ᵒC 200 W 74.21 SCCM 54 Pa 
Table 2: Process parameters for Ion Milling experiments 
3.2.1 Case 1:    
Temperature - 25ᵒC, Power- 100 W, flow rate- 45 SCCM, Pressure- 31.45 Pa 
Samples were of both types; bare AAO 
membranes and carbon coated 
membranes, with amorphous carbon layer 
present. The experiment was run for 10, 
20 and 30 minutes. 
Its observed that Ion milling at this 
specification did not have much effect on 
the membranes. Both samples, even after 
30 minutes did not show significant signs 
of material removal as seen in Fig. 3.8.  
3.2.2 Case 2 
Temperature – 25 C, Power- 200W, Flow rate- 10 SCCM, Pressure – 12.97 Pa 
Using a lower pressure as recommended by SAMCO Engineers, etching was carried out again on similar 
samples, both bare and carbon coated. Using a lower pressure increases the mean free path of gases. This 
increases the probability of an ion striking the surface of the membrane. Also since inter-ionic collisions 
are reduced, it is expected that ions with higher energy will strike the surface, leading to more material 
removal. Etching under these conditions was carried out for 30 minutes, 60 minutes and 90 minutes. The 
 
Figure 3.8: SEM micrograph, normal view of carbon coated 
membrane after 30-minute ion milling. No material removal 
is observed.  
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SEM micrographs in Fig. 3.9 show that considerable material removal took place at the end of 90 
minutes. In contrast, carbon coated membranes showed very little material removal as compared to bare 
membranes, promoting the idea that removal of lattice layer prior to CVD might be easier.  
 
3.2.3 Case 3 
Wet etched 7 minutes, 1M NaOH 
Temperature – 25 C, Power- 200W, Flow rate- 74.21 SCCM, Pressure – 54 Pa 
Membranes were first etched for 7 minutes using 1M NaOH. The method of etching was different 
because a small volume of etchant utilised to minimize etching from inside open pores as shown in Fig. 
3.7. This time, a higher pressure was utilised i.e. a higher gas flow rate to have a larger number of free 
radicals in the plasma and thus more etching. Ion milling was carried out for 1 hour with the above-
mentioned parameters in 4 runs of 15 minutes. This was done to prevent the machine from overheating. It 
was observed that there was significant exposure of the pores. The pores also appear to be clogged by 
  
Figure 3.9: SEM micrograph of plain AAO membrane after 1.5-hour ion milling. Pits and 
craters can be seen, indicating material removal. (A) Normal View (B) 35° Tilt view showing 
non-uniform etching. Scale bar 1µm 
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debris, which can be seen in Fig. 3.10. However, this is an encouraging result since removal of lattice 
layer is explicit and ordered pores can be identified.  
In the above processes, it was observed that ion milling had the potential to remove the lattice later but 
left the membrane with an uneven surface morphology. Ion milling is also not a physical process but a 
plasma based process which can potentially vary on different equipment. It is also important to note that 
carrying out CVD on clogged membranes with an uneven morphology would not result in coplanar 
CNTs. To overcome these disadvantages, other methods were considered. 
3.3 Mechanical Polishing  
The most desirable fabrication process is one that poses least variability, easy scale up opportunities and 
preferably can be carried out without the use of cleanroom facilities. Since the lattice layer is about 1µm 
deep from the top of the surface, polishing was considered as a potential option. Mechanical polishing 
poses the advantage that it is easy to scale up, is free of cleanroom requirements and is not subject to 
variations due to plasma or other dynamic systems.  
 
 
Figure 3.10: SEM Micrographs of bare AAO membranes after 7 minutes wet etching using 
‘drop method’ and subsequent ion milling for 1 hour. (A) scale bar 5µm (B) scale bar 2µm. 





3.3.1 Case 1: Polishing bare AAO membranes: 
 
Bare AAO membranes were polished on a Struers TegraPol using 1µm DiaPro diamond suspension. The 
polishing set up is shown in Fig. 3.11. Bare membranes were subjected to 12 minutes of polishing at 
150RPM.  
In Fig 3.12 and 3.13 it is seen that the lattice layer seems to have been eliminated and pores are visible. 
The pores are clogged with debris from polishing. Further trials were carried out using polishing followed 
 
Figure 3.11: Polishing set up schematic 
 
Figure 3.12: top down view micrographs of polished membranes, 15N, 150RPM (A) 3 minutes 
(B) 6 minutes (C) 9 minutes (D) 12 minutes, scale bar: 1um (A, B), 500nm (C, D) 
 
 
Figure 3.13: Top down micrographs of polished membranes with increasing force (A) 20N 
(B) 25N (C) 30N, for 5 minutes. Dark spots are covered pores. Scale bar 1um 
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by wet etching. After 3 minutes of polishing at 15N, there is significant reduction in the lattice, shown in 
Fig. 3.14 (A) By increasing force to 30N and stepping up the time to 18 minutes, there is a very clear 
elimination of lattice from the surface of membranes seen in Fig. 3.14 (B). This brings us to a definite 
conclusion that polishing is a very promising process for this task.  
These membranes were then annealed in preparation for CVD. Polished membranes after annealing 
resulted in curling of the membranes which rendered them imperfect for cell culture studies. Since 
polishing is a non-selective process, it can be carried out after the CVD step thereby leading to the 
reduction in steps, increasing yield by reducing damage to membranes during the polishing process and 
preventing polished and annealed membranes from curling during the CVD process.  
 
Figure 3.14: SEM micrographs showing polished bare membranes (A) 12 minutes, 15N (B) 
18 minutes, 30N.Both were followed by 3 min etching with 1M NaOH Scale 2µm 
 
 
Figure 3.15: Top down micrographs of CNT arrays. Polished for 20 minutes at 30N, etched 




3.3.2 Case 2: Polishing carbon coated devices 
 
In Fig. 3.15 polished and etched CNT arrays are shown. The crusty appearance of the CNT arrays was 
found to be due to excessive sputter coating in preparation for electron imaging. Some amount of 
clogging can be observed within the CNTs. The cause and solution to clogging will be further discussed 
in the following chapter.  
From the above images, following conclusions can be drawn: 
1. Polishing is a simple and effective technique to eliminate the lattice layer. 
2. There exists control over the polishing process through mutually independent variables such as 
time and force 
3. Clean room facilities are not required for polishing 
4. Scaling up of polishing will be a much simpler operation than scaling up of a dry etching process 
5. Polishing poses a higher risk of damaging membranes 
Based upon the above points, it was decided that polishing, combined with wet etching is the most 
feasible fabrication technique for mass production of CNT arrays. Hence, further studies were dedicated 




Chapter 4: Effects of Synthesis Parameters on Carbon 
Nanotubes 
 
After analyzing the observations made during experiments mentioned in chapter 4, it was clear that 
mechanical polishing was a viable alternative solution for the fabrication of CNT arrays. To effectively 
implement a fabrication process, it becomes important to comprehend in totality the behavior of the 
process under varying conditions. It was also important to understand the extent to which this process 
could be controlled in order to yield CNT array devices of required dimensions such as tube height and 
diameter. In this chapter, effects of the different process parameters with respect to physical properties of 
CNTs are discussed. During the polishing – wet etching process, the following parameters can be 
controlled: 
Polishing: Force, time, size of polishing particles 
Wet etching: Etchant, concentration of etchant, time 
4.1 Effect of Polishing Parameters 
Mechanical polishing was shown to potentially eliminate the lattice layer and overcome the issues 
associated with plasma based processes. The image in Fig. 5.1 depicts the polishing set up: 
1. Mounting of carbon deposited membranes on aluminum stubs: Aluminum stubs were cleaned 
thoroughly with acetone to make sure they were free of impurities and leftover wax from earlier 
processes. The stubs were then heated to 150 – 160°C on a hot plate, this is twice the flow point 
(78°C) of the 7071 Blanchard wax used. When stubs are warmed up, a stick of 7071 Blanchard 
holding wax (acquired from the J.H Young Co.) is used to apply a thin layer of wax on their 
surface. The wax so applied should be even thickness and have no air bubbles. The device is 
placed on the wax and let allowed to settle down for 45s – 1 minute, until it is seen that the entire 
surface of the devices contacts wax (this is confirmed by observing the wetting of the devices by 
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the wax which can be visibly observed). Any section of the membrane not in contact with that 
wax poses an increased risk of the device cracking during polishing. Care should be taken at this 
point to make sure that the wax film is even, this is imperative to prevent high and low spots on 
the mounted device and ensure even polishing. The stub is then allowed to cool down to room 
temperature. Excess wax can be cleaned by rubbing gently on a Kim wipe wetted with acetone.  
2. Polishing: The stub is placed in the holder of the Struers TegraPol and polished with set force for 
a given time. The MD-Floc polishing pad should be lubricated with 4-5 drops of green water 
based lubricant for every 5 minutes of polishing. After polishing, stub is placed under running 
water to clean off polishing slurry and allowed to dry under an air dryer.  
3. Dismounting of polished device from stub: The stub with the device on it is heated to 140°C on a 
hot plate. When the stub is warmed up, acetone is poured using a dropper on the stubs to help 
dissolve wax and free the device. Using constant addition of acetone via a dropper, the device is 
picked up using tweezers and rapidly transferred to a vessel containing 99% acetone.  This is 
carried out rapidly with great care to prevent the solidification of wax on the device which can 
result in the contraction of the wax and excess strain on the device resulting in damage or curling. 
The device is left in the acetone bath for 5 minutes to dissolve remaining wax. The device can 
now be removed from the acetone bath and allowed to dry. If visible traces of wax remain on the 







Figure 4.1: Polishing set up for CNT arrays 
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4.1.1 Effect of Polishing Time: 
The AAO template does not have pores with a constant diameter through the cross section. The diameter 
of pores varies along the thickness of the membrane. This is illustrated in Fig. 3.10. With an increase in 
polishing time, it was hypothesized the diameters of exposed CNTs can be controlled due to an increased 
removal of template material and exposure of wider or narrower pores.  
Experiment: 
AAO membranes without carbon on them were mounted on aluminum stubs using 7071 Blanchard wax 
acquired from Stronghold Wax Company. They were then polished for time periods ranging from 5 
minutes to 30 minutes in increments of 5 minutes using Struers DiaPro 1µm polishing suspension. 
Membranes were then etched in 1M NaOH for 3 minutes to clear polishing debris from the surface and 
expose pores while minimizing the effect of pore widening. They were then sputter coated for 3.5 minutes 
with Pd/Au to prepare for SEM imaging. Imaging was carried out on Tescan Mira 3 FESEM, 20kV gun 
voltage and 9mm working distance. All images were captured at a magnification of 40kx.  
Measurement of pore sizes was carried out using NIH ImageJ. Images were adjusted for threshold and 




Depending upon the number of pores in an image, between 700-800 measurements were taken from each 
image. 2 images from different regions of the same membrane were analyzed.  
Results: 
Figure 4.2 shows SEM micrographs of the membranes after polishing and wet etching. The dark and light 
bands on the edges are caused due to charge build up during imaging. Visually, the pores appear to have 
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been perfectly exposed with no sign of the lattice layer. The graphs in Fig. 4.3 show average pore size and 









Figure 4.2: Membranes polished at 30N for (A) 5minutes (B) 10 minutes (C) 15 minutes (D) 





Figure 4.3a: Variation of pore hydraulic diameter with increasing polishing time at 30N (A) 5 





Figure 4.3(b): Variation of pore hydraulic diameter with increasing polishing time  




Observations and conclusions: 
From the above data, a slight 
decrease in the average pore size is 
observed with increase in polishing 
time. This suggests that after just 5 
minutes, the membrane has been 
polished to expose pores higher than 
250nm in diameter and as polishing 
continues, a decrease in pore size 
can be observed. This indicates that 
polishing is taking place within the ‘neck’ area of the pores, after the lattice layer. The error bars indicate 
the standard deviation of pore sizes within a sample. The standard error value indicates that there is 
significant difference between pore sizes when polishing time is raised from 5 minutes to 10 minute and 
 
Figure 4.4: Change in Hydraulic Diameter with Polishing Time. Error bars show SD. 
5 10 15 20 25 30
Hydraulic Diameter (nm) 271 241 245 224 223 224

















Change in Hydraulic Diameter with Polishing Time
 
Figure 4.5: Cross section view of membrane showing 
region exposed by polishing in blue. Not to scale 
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further on to 20 minutes. There is no increase in the hydraulic diameter with polishing, suggesting that 
material is not removed to more than a few microns below the lattice layer as shown in fig. 4.5. 
4.1.2 Effect of Polishing force  
The geometry of pores through the AAO membrane cross section has been well documented by (Golshadi 
2016). The pores are shown to have a vase like geometry beyond the lattice layer, starting with a wide 
opening leading to a narrower neck and a wider body, depicted in Fig. 4.5. It can be deduced that by 
controlling the depth to which the membrane is polished, exposed CNT diameters can be controlled. The 
depth of polishing could be controlled by either polishing at a higher force or polishing for longer times.  
In this experiment, AAO membranes were exposed to 7 hours of CVD at 705 °C. Membranes were then 
polished for 5 minutes using the DiaPro 1µm diamond suspension at 10N, 30N and 50N. membranes 
were then wet etched in 1M NaOH for 5 minutes at room temperature. SEM imaging was carried out 
using the Mira TESCAN FESEM at a beam voltage of 20kV. The hydraulic diameter of the tube lumen 
was calculated using ImageJ particle analysis tool. Area and perimeter of pores were recorded and 
hydraulic diameter calculated as 
4 𝐴𝑟𝑒𝑎
𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟
 . 2 images from difference regions on each membrane were 
analyzed and Students t-test assuming equal variance was used to make sure that the difference in data 
from the 2 images was not statistically significant. Fig. 4.6 shows the images used for analysis followed 
by graphs in Fig. 4.7 showing the distribution of CNT inner diameters.  
 
Figure 4.6: Top down view SEM micrographs of CNT arrays after polishing at (A) 10N (B) 
30N (C) 50N Scale bar 2µm 
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Observations and conclusions: 
 
Figure 4.7: Variation of inner hydraulic diameter of CNT with polishing force after 5 minutes 




Recordings of tube diameters from the same membrane on different regions of the membrane were not 
statistically different from each other indicating that the polishing process could result in even polishing 
across the surface. There was little difference observed between the CNT inner diameters between 
devices polished with different forces, strongly suggesting that increasing force does not necessarily 
increase the depth to which polishing occurs. With increased polishing force, the membranes were found 
to be more likely to curl during the etching step, likely due to increased internal stresses. Increasing the 
polishing force also increased the likelihood that a membrane could get stripped off the polishing stub or 
develop cracks, thus compromising its functionality or leading to a complete loss. Therefore, a polishing 
force of not more than 30N was considered ideal for the process while keeping time as the variable 
parameter to adjust depth of polishing.  
4.2 Wet Etching: 
The aluminum oxide template used is an amphoteric oxide, soluble in both acids and bases. Wet etching 
of aluminum oxide is commonly carried out using NaOH or H3PO4. In this section, the effect of etching 
time and etchant molarity upon CNT height is discussed.  
4.2.1 Effect of etchant concentration:  
To better understand etch rates with respect to changing concentration etchants, CNT array devices were 
etched with NaOH ranging from 1M to 9M concentration after polishing for 5 minutes at 30N. CNT 
height measurements were carried out manually using ImageJ on SEM micrographs captured at 35° stage 
tilt. 200 data points were recorded from each image. Fig. 4.8 shows the qualitative change in array 
devices with increasing molarity of etchant. Pore widening is observed to be the limiting factor for tube 
heights when wet etching is used. Tube height distribution is shown in Fig. 4.9. 
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Results and Observations:  
 
 
Figure 4.8: 35° tilt micrographs of CNT array devices etched with NaOH (A) 1M (B) 2M (C) 
3M (D) 5M (E) 7M (F) 9M Inlets showing top down view and pore widening. Scale bar 2µm, 





Figure 4.9: CNT height distribution after etching 5 minutes with NaOH (A) 1M (B) 2M (C) 3M 
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A consistent increase is observed in the CNT heights up to 3M concentration, as seen in fig. 4.10. The 
regime between 3M and 7M concentration does not show significant difference in tube heights. This is 
attributed to the isotropic nature of wet etching and resulting pore widening. Both the edges around the 
tubes and the bulk of the membrane experience the same etch rates. However, there is much lesser 
material to etch at the edges as compared to the bulk. Therefore, in a given amount of time, more of the 
edge gets etched, leading to a rapid widening of the pore instead of uniform top-down etching. 
Pore widening poses the risk of CNTs losing their structural support from the template and potentially 
clumping, if excess etching is carried out. It also adds ambiguity to the measurement of CNT heights 
because the actual point of intersection between the template surface plane through the CNT cannot be 
identified. Thus, CNT measurements from devices with significant pore widening cannot be accurately 
judged. 
4.3 Conclusion 
Polishing and wet etching can be controlled to yield CNT arrays of desirable physical parameters in a 
fraction of the time as compared to reactive ion etching. A typical polishing process will take 10 minutes 
of process time to yield 6 membranes compared to 6 hours for RIE. Thus, polishing and wet etching are 
significantly quicker and cheaper processes.  
 
Figure 4.10: Mean CNT height after etching for 5 minutes with varying NaOH 
concentrations 
1 2 3 5 7 9
















Chapter 5: CNT Quality Control 
CNTs fabricated through polishing and wet etching display quality issues unique to the polishing process. 
Polishing, being an abrasive process, poses the risk of damaging CNT arrays due cracks induced in the 
template during the process, uneven polishing due to improper mounting of CNT devices on polishing 
stub and microscale damage to CNTs from polishing particles. This chapter presents a qualitative 
assessment of CNT arrays using electron microscopy as the primary investigative tool. All SEM 
micrographs were captures on the TESCAN Mira3 FESEM, with an accelerating voltage of 20kV unless 
mentioned otherwise.   
5.1 Clogging of CNTs 
 
As seen in Fig. 4.1 earlier, the polishing set up consists of a number of materials which are directly 
involved in contact with the polishing pad and may lead to clogging of nanotubes. Clogging throughout 
this chapter is classified as 3 types, shown in fig. 5.1. Type 1 clogging indicates highly clogged pores 
which are often found alongside damaged tubes. Type 2 clogging is less compared to type 1 and less tube 
 
Figure 5.1: SEM micrographs of CNT arrays showing possible clogging (A) Type 1: Highly 
clogged and damaged, white circles show clogging in tubes (B) Type 2: Light clogging and 
minimal damage (C) Type 3: No clogging, no damage. Scale 500nm  
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damage is observed. Type 3 indicates well formed, unclogged CNTs with no damage. The presence of 
obstructions in CNTs can be undesirable if CNT devices are used for fluidic applications such as 
intracellular delivery or as a component of a microfluidic system. In order to understand the cause of 
clogging and methods to eliminate it, a number of experiments were carried out. 
Membranes during polishing come in contact with several materials. Blanchard holding wax, a commonly 
used wax for polishing silicon wafers in the microchips industry, is used to hold the AAO membranes 
onto the polishing stubs machined out of aluminum. The polishing pad used is a Struers MD FLOC non-
woven fiber pad. Polishing slurries used were 1µm, ¼ µm Struers DiaPro (Diamond) and 0.05µm alumina 
(powder suspended in water). With the above set up, 4 major elements can be identified as the potential 
source of clogging in CNT arrays: 
• Diamond – from polishing suspension 
• Wax – Used to hold the devices on the stub 
• Alumina  
• Carbon – from CNT devices 
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5.1.1 Identification of clogging source - Wax 
Initial hypothesis suggested that due to improper 
cleaning, residual wax was responsible for clogging 
the CNTs. This problem was not observed when plain 
membranes were polished with or without wax 
suggesting that the decreased diameter of lumen after 
carbon deposition was affecting the ability of acetone 
to completely remove wax. Since wax is soluble in 
acetone, longer acetone wash times, higher 
temperatures and ultrasonication in acetone were 
experimented with to understand its effect on 
clogging. Fig. 5.3 shows the results after the different 
rinsing processes. 
 
Figure 5.2: Bare membrane polished for 
5 minutes, 30N. No clogging observed. 
Scale 2µ 
 
Figure 5.3: Top down micrographs of CNT arrays after (A) rinsing in acetone (40°C) (B) 
Rinsing in water (100°C) (C) After forcing acetone through CNTs using syringe. Type 2 
clogging observed in all specimens. Scale 1µm 
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In the images shown in Fig. 5.3, it can be observed that clogging is persistent in all CNT devices despite 
the processing technique utilized. These experiments indicated that the hypotheses of wax clogging the 
nanotubes was likely to be a weak hypothesis and other causes should be considered. However, the 
experiments did not indicate a complete breakdown of the hypothesis since it could not be confirmed 
whether the acetone was truly effective at dissolving wax from the CNTs. Thus, these experiments 
assumed that acetone is 100% effective at dissolving all wax. To confirm the hypothesis, polishing was 
carried out without using wax as a mounting agent for 5 minutes and 30N followed by 5 minutes of 
etching with 1M NaOH. CNT arrays were mounted using Kapton tape on to aluminum stubs and 
polished. The resulting micrographs, shown in fig. 5.4, showed type 1 clogging in the CNTs, thereby 
confirming the hypothesis that wax was not 
responsible for clogging the CNTs.  
5.1.2 Identification of Clogging Source – 
Aluminum Oxide 
Aluminum oxide, if involved in clogging the 
CNTs, should ideally have been dissolved by 
the action of wet etchants such as NaOH or 
phosphoric acid. It is possible that due to the 
small diameters of CNTs, etchants were not 







Figure 5.4: Top down micrograph of CNT array, 
polished without wax, 5mins, 30N. Clogged 
tubes encircled.  
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To overcome this, X-ray microanalysis using scanning electron microscopy (SEM) was utilized.  
 
The image in Fig. 5.5 strongly suggests that alumina is present in some quantities in the clogged pores. It 
must be noted that EDX results cannot be taken as conclusive but were used as a guide for future 
experiments. To eliminate traces of alumina from the clogging, devices were exposed to reactive ion 
etching using BCl3 and wet etching techniques. It was expected that BCl3 will result in selective etching of 
AAO and a reduction in clogging can be observed.  
 
Figure 5.5: EDX spectra overlay - showing aluminum in red. Clogged pore circled. Red color 
suggests presence of aluminum 
 
Figure 5.6: Top down micrographs of CNT devices processed with RIE for (A) 15 minutes 
(B) 30 minutes (C) 45 minutes followed by wet etching for 5 minutes with 1M NaOH. A, B 




Reactive ion etching was carried out for 15, 30 and 45 minutes at a flow rate of 20SCCM argon and 
80SCCM BCl3 on different devices immediately after polishing. The devices were then subject to wet 
etching with 1M NaOH for 5 minutes. It was expected that reactive ion etching will selectively etch away 
aluminum oxide, thereby unclogging the tubes to some degree. The images in Fig. 5.6 show that RIE has 
influenced the clogging of CNT arrays but type 1 clogging is seen in Fig. 5.6 (C) and type 2 in panels A, 
B. The devices used for this batch of experiments also show some variability in polishing but clogging is 
observed in all sections of the devices irrespective of the quality of polishing. Further experiments were 
carried out using by using variations of wet etching.  
In Fig. 5.7, all devices were etched using 1M NaOH for 5 minutes unless specified. Significant etching 
has taken place when using higher concentration of NaOH or warm NaOH, indicated by the presence of 
pore widening. However, clogging is still observed in the CNTs. With the increase in NaOH 
concentration, an increase in the viscosity and surface tension of solution is observed. To enable better 
access to the CNT lumen, a lower molarity of NaOH was used to etch the device for a second round. 
Using a lower molarity of NaOH for a second round of etching after 5 minutes of etching with 1M NaOH 
also did not show any reduction in clogging.   
 
 
Figure 5.7: Top down micrographs of CNT devices etched with (A) 7M NaOH for 5 minutes 
(B) 9M NaOH for 5 minutes (C) 1M NaOH for 5 minutes followed by 0.1M NaOH for 5 
minutes (D) 1M NaOH, ~40°C, 5 minutes, Scale 1µ 
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5.1.3 Identification of Clogging: Carbon  
 
Since all the methods above selectively dissolve or etch away aluminum oxide, it could be concurred that 
aluminum oxide was not the primary element responsible for clogging of CNTs because there appeared to 
be negligible change in the number of clogged CNTs in each experiment. This in conclusion implied that 
the clogging was most likely being caused by carbon being smeared from damaged CNTs during the 
polishing process. 
In order to confirm the hypothesis, attempts were made to oxidize carbon using oxygen plasma etching. 
The 2 routes to eliminate carbon from the polishing process are shown in Fig. 5.8 below. In route A, 
carbon is etched away prior to polishing and therefore is not involved in the polishing process, 
eliminating any possibility of it clogging the CNTs. In route B, carbon is etched after CNTs have been 
exposed. In an ideally controlled process, just the right amount of etching would take place to eliminate 
the clogging. In the case of excessive etching, the CNT array could be further wet etched to dissolve more 
of the membrane and re-expose nanotubes. Since, neither of the processes provide an advantage over the 
other, the selection criteria were limited to the route which would offer better control over the geometry 





In Fig. 5.9 below, results from method A are shown. Initially oxygen plasma (SAMCO RIE-1C) was 
carried out for 2 and 4 minutes at 50SCCM flow rate and 200W RF power on carbon coated membranes 
prior to polishing. The devices were then polished for 25 minutes at 30N and etched in 1M NaOH for 5, 
8minutes. It is seen that carbon is completely etched off in some regions from the membranes and no 
clogging is observed. Plasma treatment therefore resulted in excessive etching. To better control the 
process, oxygen plasma was carried at 50W and 50SCCM on carbon coated devices and followed by 25 
minutes of polishing at 30N 5, 7 minutes of etching in 1M NaOH. In fig. 5.10 (A, B) are images from 2 
different membranes. (A) displays clogging while minimal tubes are observed in (B). Since the etch rate 
of amorphous carbon within the geometry of porous membrane is not documented, it was not possible to 
estimate the depth to which carbon was being etched. From 5.10 (A, B) it is clear that the process presents 
variability. Owing to the above factors, it was decided to try route B shown in fig. 5.8.   
 
Figure 5.8: Schematic depicting two methods of implementing oxygen plasma to remove 
carbon (A) O2 plasma is used to eliminate carbon from the polishing process (B) O2 plasma is 








Figure 5.9: SEM micrographs of devices after O2 plasma at 50SCCM, 200W (A) 2 minutes 
(B) 4 minutes followed by polishing for 25 minutes at 30N and wet etching for (A) 5 minutes 
(B) 8 minutes. Scale 2µm 
 
Figure 5.10: CNT arrays fabricated using procedure outlined in fig. 6.8 (A). O2 plasma 
carried out at 50SCCM, 50W for 1 minute followed by polishing for 25 minutes, 30N (A, B) 





We observe that despite the layer of debris from polishing, oxygen plasma significantly reduced clogging 
in the carbon nanotubes. With increasing oxygen plasma time, the number of unclogged pores increases 
significantly.  The removal of clogging appears to be a relatively quick process since pores are observed 
with clogged CNTs or completely clean. This gives strong evidence for the hypothesis that clogging is 
caused primarily due to carbon.  
 
 
Oxygen plasma was also carried out on polished devices after etching, to understand whether the process 
of eliminating clogging could be controlled when nanotubes are exposed. Fig. 5.11 shows the resulting 
devices after 60, 90, 120 seconds of oxygen plasma at 50W, 50SCCM of oxygen flow. The devices were 
etched again in NaOH after oxygen plasma to increase the length of exposed tubes. After 1 minute of 
treatment with oxygen plasma, seen in Fig. 5.11 A (i), certain regions of the membranes show excessive 
etching and no tubes are observed. In Fig. 5.11 (A (ii)) clogged tubes of type I are observed.  After 2 
minutes of treatment and more, almost all carbon is etched away and no nanotubes are observed on the 
surface, implying excessive etching.  
Although oxygen plasma treatments were successful to a limited extent in helping unclog the CNT 
devices, a high level of variability and lack of control made the use of O2 plasma unfeasible.  
Corona plasma treatment was also briefly explored as an aid to unclog the CNT arrays. A corona 
discharge is formed when a highly charged conductor ionizes the insulating fluid around it, in most cases 
this fluid is air. The corona discharge will result in the production of ozone and other ions. A handheld 
corona discharge device known as the plasma wand was used for this task. Since CNT devices are 
conductive, an arc was formed between the conducting tip of the corona device and CNT device. 
Membranes were treated either before etching or after etching for 30s and 120s. Fig. 5.12 shows the 
 
Figure 5.11: Devices polished for 5 minutes, 30N followed by wet etching for 5 minutes with 
1M NaOH. O2 plasma carried out for (A) 60s (B) 90s (C) 120s at 50W, 50SCCM flow rate 
followed by etching again for 5 minutes with 1M NaOH. Scale (A) 1µm (B) ½ µm (C) 1 µm 
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results of the experiment. In Fig. 5.12 (A, C) we can see that corona treatment immediately after polishing 
for 30 seconds does not result in a significant reduction in the clogging of carbon nanotubes in some 
region while other regions show a complete elimination of nanotubes. After 120s of corona treatment, 
CNTs have been etched and bare AAO can be observed. The process exhibits a high amount of localized 
variability.  
5.2: Effect of CVD Time and Membrane Position in Furnace on CNTs 
It was found that the position of membranes on the CVD holder, referred to as the ‘boat’ and CVD time 
had a major effect on the clogging of CNT arrays. The following experiments were carried out to 
qualitatively observe how CVD time and membrane placement affects CNT quality.  
Experiment 1: 
The CVD boat consists of 35 slots, of which 9 were filled as shown in fig. 5.13. The membranes were put 
through CVD for 5 hours and 7 hours. Membranes were then taken in groups of three, depending on their 
position in the boat (near gas inlet, center, near exhaust). 1 membrane in each group was polished with 
 
Figure 5.12: Plasma wand used before etching (A) 30s (B) 120s, Plasma wand used after 




15N force for 5 minutes while the other two in the group were polished at 30N for 5 minutes followed by 
5 minutes of wet etching with 1M NaOH. The results are shown in fig. 5.14 and 5.15 below.  
 
Figure 5.13: Arrangement of membranes to study CNT quality changes due to position in 
tube furnace and CVD time 
 
Figure 5.14: SEM micrographs of 5-hour CVD (A, C, E) 15N 5 min polished devices (B, D, 
F) 30N 5 min polished devices (A, B) near exhaust (C, D) center (E, F) near inlet. Scale 2µm 
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The position of devices in the polishing equipment 
holder was also tracked to rule out any variability 
due to the polishing set up.  
Results: It was observed that after 5 hours of CVD, 
irrespective of polishing force, CNTs were easily 
damaged during the polishing process and appeared 
to be clogged. CNT wall thicknesses appear to be 
consistent across all samples indicating uniform 
carbon deposition. After 7 hours of CVD, an 
interesting observation was made. Specimens closer 
to the exhaust seem to have lesser clogging in the 
Figure 5.15: SEM micrographs of 7-hour CVD (A, C, E) 15N 5 min polished devices (B, D, 
F) 30N 5 min polished devices (A, B) near exhaust (C, D) center (E, F) near inlet. Scale 2µm 
 
Figure 5.16: Unclogged, undamaged tubes 
after 7 hours CVD. Device was placed near 
exhaust during CVD. Scale 1000nm  
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tubes and displayed lower tube damage, despite equivalent tube wall thicknesses. This experiment was 
repeated to confirm results, seen in fig. 5.16. 
 
Figure 5.17: Experimental set up to study variation in CNT quality after polishing due to 
membrane positioning in sample holder and interdependence of membranes in different 
positions. CVD carried out for 7 hours 
 
Figure 5.18: Membranes imaged corresponding experiments described by fig. 6.17. (A) 
Type 1 clogging observed in all samples (B) No clogging in one sample (shown here). Inlet 
shows tube damage (C) Type 2 clogging observed. All specimens imaged were from the 
group near the exhaust. Scale 2µm (A, B scale is the same), (B inlet) 200nm 
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A third experiment was designed to study whether the removal of membranes from other positions in the 
boat would yield similar results. In this experimental set up the boat was filled with membranes as shown 
in figure 5.17. The membranes were then exposed to 7 hours of CVD and polishing at 30N for 5 minutes 
using 1µm diamond slurry followed by etching using 1M NaOH for 5 minutes. Fig. 5.18 shows the results 
of this experiment. Only the marked membrane showed unclogged tubes. This result strongly suggested 
an interdependence of membranes in different positions with respect to how devices reacted to polishing.  
 
To verify that CNTs were unclogged all the way through, cross section of etched, broken membranes was 
imaged. In Fig. 5.19, the CNTs show no clogging, neither at the upper opening of the CNTs nor in the 
lower sections. In the clogged CNT arrays, it is seen that the clogging does not extend down below the 
very top, implying that there are no impurities that remain in the tubes from the polishing process. This is 
an important observation since the presence of impurities within the nanotubes would pose larger 
problems for the purposes of cleansing as compared to impurities at the very openings. 
 
Figure 5.19: Cross section view of membranes (A) No clogging is observed in the tubes 
below the surface (B) Unclogged membrane, no clogging in tubes below surface. Thus, 
clogging is only on the surface. Scale (A) 1µ (B) 2µ 
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Although unclogged CNTs could be obtained 
by the above-mentioned method, it added 
time to the process while reducing yield by 
50% because only 3 membranes at a time 
could be obtained unclogged. Unclogged 
membranes also displayed signs of tube 
damage and jugged CNT walls as shown in 
fig. 5.20. 
The issue of clogging was also studied with 
respect to the grain size of polishing slurry 
used. The following solutions were available 
for use: 
1. Struers DiaPro Nap 1µm  
2. Struers DiaPro Nap ¼ µm 
 
Figure 5.20: Arrows showing jagged tube walls 
 
Figure 5.21: 35° tilt micrographs of CNT arrays polished using (A) 50nm Alumina for 5 minutes 
at 30N, inlet shows top down view of tubes (B) ¼ µ DiaPro for 5 minutes, 30N, inlet shows top 
down view. Scale (A) 2µ, inlet 500nm (B) 1µ, inlet 250nm 
89 
 
3. Electron Microscopy Sciences: Type DX alpha alumina powder 0.05µm  
The Struers acquired suspensions are proprietary suspensions of mono-crystalline diamonds, coolant and 
lubricant to minimize heat generation during the process and increase the life of the polishing pad. The 
Alumina powder was mixed with water or Struers proprietary DP Green Lubricant. Results of polishing 
from the different suspensions are shown in Fig. 5.21. A marked observation is that the reduction in 
suspension size has a marked increase upon the smoothness of tube walls and reduction of clogging 
within CNTs. The DX alpha alumina powder shows the best results with respect to clogging, however, 
due to the lack of lubrication, coolant and imperfect concentration of particles, accelerated polishing pad 
wear was observed along with increased damage to membranes during the polishing process.  
In conclusion, alternative processes of fabrication have been developed which can produce CNT arrays of 
quality comparable to CNT arrays produced via dry etching in a fraction of the time. The use of smaller 




Chapter 6: Cell Culture on CNT arrays and Transfection 
To confirm that CNT array devices were 
ready for use with cell transfection, basic 
fluid flow experiments were carried out. 
These experiments were not designed to 
quantify fluid flow parameters through 
nanotubes but rather to confirm that flow of 
fluid was possible through the devices. The 
experiment was set up as follows.  
Devices were placed cell growth side down 
on a sheet of paper and a drop of DI water 
was placed on the device. The device was 
covered to prevent evaporation of the drop. 
After 2 hours, wetting of paper under the 
device confirmed that water had gone 
through the CNT array, depicted in Fig. 6.1 
below.  
 
6.1 Cell culture – Experiment 1: 3T3 Cell Growth on CNT arrays 
The first experiment to study cell growth was carried out on devices that had been exposed to 3 minutes 
of oxygen plasma at 300 mTorr, 250W RF power and 100 sccm of oxygen flow. The devices were then 
wet etched using 1M NaOH for 15, 17 and 20 minutes.  The aim of this experiment was to understand 
basic cell culture protocols and handling of equipment in a tissue culture room.  
 
Figure 6.1: (A) Devices placed on dry paper with 
water droplet (B) wetting observed under device 
after 2 hours, confirming fluid flow capability 
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Cells used were of the NIH/3T3 type fibroblasts. Cells were detached from cell flask by letting them sit in 
trypsin for 7 minutes. Trypsin was aspirated and Dulbecco’s Modified Eagle’s Medium (DMEM) was 
added to neutralize the effects of trypsin. 20µl of cells in media was taken and dyed blue with 20µl of 
trypan blue to identify dead cells. 0.5µl of cells was put into a hemocytometer for counting. Each device 
was to be coated with 40,000 cells which was calculated as approximately 500µl.  
2 of 17 minute and 15-minute etched devices each were coated with cells. Devices were rinsed with 
ethanol prior to use. The devices were left to dry for 5 minutes and PBS used to rinse devices to remove 
leftover ethanol if any. 0.5ml of cell solution was added to each well and allowed to incubate for 24 
hours. To observe cells under a microscope, they were fixed using paraformaldehyde diluted in PBS 
(unknown concentration) and stained with a green actin filament dye. Images in Fig. 6.2 show cells 
growing on the devices.  
The images in Fig. 6.2 show that cells 
adhered to the surface of the CNT array 






6.2 Cell Culture – Experiment 2: HE293 Cell growth and EYFP transfection attempt 
HEK 293 cells were cultured on CNT array devices fabricated using mechanical polishing. Devices were 
fabricated by carrying out CVD for 5 hours followed by polishing for 5 minutes at 30N of force using 
DiaPro 1µm diamond suspension. The devices were then etched using 1M NaOH for 3 minutes, 5 
 
Figure 6.2: Fluorescent image of fixed 3T3 cells 
on CNT array etched for 17 minutes with 1M 
NaOH (A) 20x (B) 100x 
92 
 
minutes and 7 minutes. The CNT heights were measured as 104 ± 30nm, 114±30nm and 134±39nm for 3 
min, 5 min and 7 min etched devices respectively. The distribution of tube heights can be seen in fig. 6.3. 
48,000 cells were added to each device as a drop on the CNT devices facing cell growth side up. The cells 
were allowed to adhere onto the device for 2 hours. 1ml of DMEM was added to the wells and cells 
 
Figure 6.3: CNT height distribution after etching with 1M 
NaOH (A) 3 min (B) 5 min (C) 7 min 
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allowed to incubate for 48 hours. Cells were stained using Calcein AM green to view under fluorescent 
microscope. Confluency was observed ranging between 50-70% on different locations of the devices. 
This can be seen in fig. 6.4 below.  
The devices were then transferred to the transfection set up shown in Fig. 6 and transfection was 
attempted using Venus Enhanced Yellow Fluorescent Protein (EYFP). EYFP was prepared by adding 
36µl of Venus DNA in 600µl of patch clamp buffer. 100µl of DNA was added to each device and they 
were allowed to incubate for 2 hours. 
Cells were harvested from device using trypsin after 2 hours and transferred to tissue culture plastic. They 
were allowed to incubate for 24 hours and then viewed under a fluorescent microscope. The cells were 
found to show no fluorescent activity and it could be concluded that transfection was not successful. The 
cause of failure was hypothesized as a combination of multiple issues. As seen in Fig. 3, the devices can 
be seen to possess clogging within nanotubes. CNTs were also observed to have peaks and jagged edges 
unlike the smooth coplanar surfaces of devices fabricated through RIE. In order to increase chances of 
success, the above issues were addressed in preparation for the next experiment.  
6.3 Cell Culture – Experiment 3: HEK293 Cell growth and EYFP transfection attempt 
HEK 293 cells were cultured on arrays devices fabricated via 7 hours of CVD followed by polishing for 5 
minutes at 30N. Devices were etched using 1M NaOH for 5 minutes and 7.5 minutes. As mentioned in 
Chapter 6, this method of fabrication resulted in unclogged CNTs. 5 devices were used for this 
 
Figure 6.4: HEK293 cells harvested after 48 hours from CNT arrays (A) from 3 min etched 
device (B) from 5 min etched device (C) from 7 min etched device 
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experiment. 3 were etched for 5 minutes and 2 were etched for 7.5 minutes. Devices were coated with 
48,000 cells and allowed to incubate for 2.5 hours. 2ml of DMEM was added to each of the 5 wells 
containing CNT devices after 2.5 hours and 1 ml of DMEM was added to the control well in a 24-well 
plate. Cells were dyed red using CellTracker CMTPX. Dye was prepared by adding 50µg of CellTracker 
red to 70µl of Dimethyl Sulfoxide (DMSO). 2µl dye was added to 2ml of media in 6 well plates and 
allowed to sit for 30 minutes. Cells were then viewed under a rhodamine filter and had appeared to have 
achieved confluency of 90%. Lipofection was used for the control experiment. 50µl Jet Prime buffer was 
mixed with 1µl jet prime reagent and 0.5µg of Venus YFP. Control well media was aspirated and 0.5ml 
of fresh media added and the lipofection solution added. For transfection using CNT devices, 600µl patch 
clamp buffer was mixed with 36µl Venus DNA. Each device received 100µl of Venus DNA solution.  
Devices were pulled out of the incubator after 2.5 hours and transferred to new well plates.  They were 
viewed again under the rhodamine filter and appeared to be confluent. It should be noted at this point that 
the microscope was not equipped with a camera and thus images were not acquired. Devices were washed 
with trypsin and cells were transferred to 6 well plates, allowed to incubate for 24 hours. Very few cells 
were observed after 24 hours and no fluorescence was observed either. In contrast, the control well cells 
fluoresced bright yellow. This indicated another failure in transfection. The leading cause for this failure 
was identified as mishandling when cells were harvested from CNT array devices to well plates after 
transfection. Also, cells were plated on the device for only 24 hours prior to transfection. According to 
Golshadi, the time that cells were allowed to grow on devices prior to transfection had a significant 
impact on transfection efficiency. The low concentration of DNA was as also cited as a major reason for 
lack of fluorescence. Transfection using CNT array device requires a much higher concentration of DNA 
as compared to lipofection.   
In parallel with this experiment, the following set up was also tested for transfection. Fig. 6.5 shows a 
Whatman paper which has been wetted with DMEM. Instead of laying CNT devices on cylinders, the 
device was laid down cell side down on the Whatman paper. Protocols for cell culture, dye preparation 
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and DNA preparation followed were the same as above in this experiment. Cells were transfected in the 
same method as above. Cells were found to adhere well to the device and did not adhere to the Whatman 
paper. However, no transfection was observed. This method has potential for reducing device damage and 
improve ease of handling during the transfection process.  
Keeping in mind the above-mentioned drawbacks, the next cell culture experiment was carried out using 
propidium iodide (PI), a cell impermeable dye and cells allowed to culture for 48 hours.  
6.4 Cell culture – Experiment 4: HEK293 Cell Growth, PI injection 
3 devices were used for this cell culture experiment. The devices were exposed to CVD for 7 hours, 
followed by 5 minutes of polishing at 30N using 1µm DiaPro diamond suspension. The devices were then 
wet etched for 5 minutes and 7.5 minutes with 1M NaOH. Each device came from 3 distinct regions of 
the boat. Calcein AM purple was used to stain cells for fluorescence and Propidium Iodide was used as 
cargo for delivery inside cells. Calcein Purple was created by adding 42µl of sterile DMSO to 25µg of 
dye. 40µl of this solution was added to 1250µl of buffer to create 200x working solution. For 6 wells, at 
1ml per well, 30µl of working solution was needed. Propidium Iodide was used at 75µm concentration in 
patch clamp buffer (PCB). A 100x stock solution was made by adding 5mg of PI per 1ml of PBS. 
Therefore, the final solution required 300µl of PCB in 3µl of 100x PI.  
Each device was coated with 24,000 cells by placing a 100µl drop of cells in media on the top surface of 
device. The cells were then allowed to attach for 2 hours on the surface in an incubator and 2ml of media 
was added to each well with the devices. Cells were allowed to incubate for 48 hours before transfection. 
Due to a handling error, excess PI was added on the devices, leading to quick cell death since high 
concentrations of PI can be toxic to cells. Transfection data was thus not obtained. PI was seen to have 
 
Figure 6.5: Set up for transfection using Whatman paper 
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been transferred to through CNTs. After only a small number of cells could be harvested from the device 
again.  
A critical observation from the above experiments was the small number of cells harvested after 
transfection from CNT devices. This lead to re-evaluation of the experimental set up and identification of 
potential problems.  
 
Fig. 6.6 shows the handling and manipulation required throughout the process. CNT arrays are first 
placed in a 6 well plate and sterilized using ethanol. The ethanol is allowed to dry, followed by rinsing 
with PBS. A 100-150µl drop of media containing the required number of cells is placed on the device. 
This is preferred over immersing the device in 1-2ml of media with cells to prevent cells from adhering 
and growing on the underside of the device where cargo to be transfected will be placed. Cells are 
allowed 2 hours to adhere on to the surface before each well is filled with 1-2ml of media and left to 
incubate for 24-48 hours. Devices are then transferred into the transfection set up. Each cylinder in is 
 
Figure 6.6: Schematic showing steps involved in transfection process (A) Cell adherence 
by placing a drop of cells on device (2 hours) (B) Adding media to let cells grow (48 hours) 




filled with 150µl of fresh media and device is placed such that the cell adherent surface is immersed in 
media. A drop of solution (PCB or DMSO) containing the required cargo is placed on the other side of 
the device with great care to prevent the drop from breaking and leaking into the media or sliding off the 
device. The set-up is placed in the incubator for 2 hours. After this step, devices are washed with PBS and 
cells trypsinized. The cells are then transferred to a new 6 well plate with 1-2ml of media and allowed to 
incubate for 24 hours to show transfection.  
In the above protocol, the first step of attaching cells to the device is rife with ambiguity about cells 
adhering to the CNT surface. Golshadi et. al had immersed CNT devices in media for 24 hours to allow 
cells to grow on the device. However, this poses the risk of cells growing on the bottom surface too. 
Moreover, due to the extremely smooth surface finish of polished CNT arrays, it is difficult to make sure 
that the drop of cells in media remains completely upon the device and much of it can slide off with ease. 
This can potentially lead to a loss of cells on the device. With a thin layer of cells on the device and high 
variability in confluency, it is likely that the cargo takes the path of least resistance like any other fluid 
flow system, allowing cargo to leach into the media below.  
6.5 3D Printed Nanofluidic Device 
Whatman Anodisc 13 alumina membranes are 60µm in thickness. This results in extreme fragility and in 
turn results in easy loss of devices by cracking during handling and manipulations carried out during 
experiments. In order to ease handling of the CNT devices, three-dimensional (3D) printing was used to 
create a support structure for the membranes. 3D printing was utilized to encapsulate the CNT array in a 
microfluidic device. In Fig. 6.7 shows the geometry of the proposed structure and different sizes of rings 
printed around a bare AAO membrane.  
The 3D printed rings around CNT devices served multiple purposes during the course of culturing 
cells and subsequent transfection. Apart from developing cracks or due to handling errors in dry 
conditions, during the production of devices, CNT devices were found to adhere to wet surfaces due to 
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surface tension. This required very delicate handling, which was operator dependent and could not be 
standardized for large-scale use. This problem was further exacerbated when the liquid in question was of 
higher viscosity as is commonly observed in with growth media in cell culture or wet etchants during 
production such as phosphoric acid (H3PO4). This lead to the device being damaged when lifting off from 
a wet surface while transferring from one culture dish to another. The 3D printed ring provided an uneven 
surface, which easily breaks surface tension and can be easily held by tweezers while minimizing the risk 
of damage to CNT device. 
During the process of transfection, the ring not only could provide physical support but also serve as a 
reservoir for the purpose of holding cargo to be delivered into cells. The thickness of 3D printed ring may 
potentially be increased to accommodate larger volumes of reagent and this also prevents tweezer - cell 
contact, thereby minimizing the risk of cell death due to any stress that might be inflicted upon them by  
 
 
Figure 6.7: (A, B, C) CAD illustrations of proposed 3D printed rings (D) 3D printed 




tweezers. Moreover, since the active area of the device is now defined by the inner diameter of the ring, it 
provides for a more confident analysis of cell growth and transfection. This is because the edges of the 
device display imperfections, which can hinder functionality. 
To demonstrate cell culture on 3D printed devices, HEK 293 cells were cultured on the 3D printed 
CNT array devices for 48 hours and stained with CellTracker Green to observe cell growth and 
morphology. Devices were coated with Polylysine to aid in cell adhesion. Cells displayed morphology 
similar to devices without support structure or standard tissue culture plastic as shown in Fig. 6.8.  
The cell growth results were as expected due to the nature of the process used to fabricate the rings. 
The PLA does not contact the bulk of CNT device surface during 3D printing and serves purely as a 
holder for these devices without affecting cell culture on the surface of the device. Thus, the presence of a 
support structure had no detrimental effect on cell growth.  
 Conclusion 
It can be concluded that cells grow on CNT array devices using regular cell culture protocol. However, 
more work needs to be done to establish a technique which will minimize loss of cells from the device to 
maximize transfection. A 3D printed support was developed to aid in handling of device and cell culture 
was demonstrated on the device.  
 
Figure 6.8: HEK 293 cells stained with CellTracker Green on (A) standard tissue culture 
plastic (B) CNT device (C) CNT device with support structure. Scale: 50 µm 
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Chapter 7: Conclusion 
7.1 Research Summary 
Carbon nanotube arrays have shown the potential to be used as a device for intracellular delivery of 
biomolecules of different size and charges into immortalized cell lines and also hard to transfect cells 
such as stem cells, neurons and macrophages. With an increased demand for novel therapeutics which 
offer features such as targeted drug delivery, personalized treatments and combination of gene therapy 
and stem cell therapy, the CNT array device can potentially be an indispensable tool for the future of 
medicine. Since carbon is a conductive material, this device also offers the potential of being used an 
intracellular probe which can carry out single cell analysis on multiple cells simultaneously. This makes it 
highly desirable for use in biomedical research applications as an aid to study cell functioning. However, 
a major limiting factor for the development of this device and expansion of its use in the scientific and 
medical community was the expensive and time-consuming fabrication process involved in their 
manufacture. Depending upon the physical requirements of the device, the time spent in etching 8 devices 
could go up to 12 hours using reactive ion etching.  
In this thesis, a number of alternative nanofabrication processes have been outlined for the production of 
CNT array with the aim of reducing time for production and increasing yield. An emphasis was given on 
avoiding processes which required clean room facilities or plasma based processes in order to minimize 
variability due to environmental and equipment based factors. This was also important to keep costs low 
and enable scaling up the production of devices. Mechanical polishing, a purely physical and 
economically feasible method, along with wet chemical etching were selected as an alternative to reactive 
ion etching. Both processes require minimal resources and can be scaled up in a linear manner at low cost. 
The effects of parameters such as polishing force, time, etching time and etchant molarity on physical 
dimensions of CNT arrays were documented. It was shown that the presented alternative processes could 
control CNT height distribution to a fine degree in a relatively short processing time ranging from 5-30 
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minutes of polishing followed by 5-30 minutes of wet etching. Compared to the reactive ion etching 
process, this implies a time saving of nearly 97%. It also has the advantage of being able to increase yield 
by using equipment with a larger holding capacity since polishing and wet etching are not dependent upon 
the scale of the device. 
The quality of CNTs was qualitatively analyzed using scanning electron microscopy. Issues associated 
with the polishing process included clogging of nanotubes, damaged tubes, cracked and broken 
membranes during polishing and rough CNT wall edges. The use of process variables such as CVD time, 
positioning of samples in CVD furnace tube and change in polishing particle size to control CNT quality 
was shown. CNTs could be produced with clogged or unclogged tubes depending upon the need of 
application.  
Lastly, cell growth has been demonstrated on CNT arrays and attempts made to transfect with EYFP and 
Propidium Iodide dye. Potential causes of failure and variability were identified.  
7.2 Future work: 
7.2.1 Future work in nanofabrication technique:  
The newly developed fabrication process can save up time by up to 97%. However, a number of issues 
such as variability in polishing due mounting membranes on the polishing set up and loss of devices due 
to formation of cracks were identified. Future work can be carried out to refine the technique and scale up 
the process. The use of alumina slurry had shown potential in producing CNTs with smooth edges, 
minimal damage and no clogging. The alumina particles in turn lead to accelerated wear of the polishing 
pad. Work on studying the right amount and type of polishing lubricant and coolants to be added would 
be a valuable input.  
Whatman Anodisc AAO membranes are extremely fragile and are easily damaged during handling over 
the course of experiments. To aid in handling the device and also providing a built-in reservoir for fluid 
over the device, fused deposition modeling 3D printer was used to print a ring around the CNT arrays. 
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This provided the CNT array device with added rigidity and ease of handling. Future work on 
incorporating more extensive 3D printed devices using CNT devices is of great interest. Development of 
microfluidic chips with CNT devices can eliminate the need to for multiple handling steps during 
experiments and provide a simple, sterile and disposable platform for carrying out transfection. 
7.2.2 Future work in cell culture and transfection 
In this thesis, only devices polished with 1µm DiaPro were used to study cell growth on CNT arrays. This 
resulted in devices that were clogged with damaged tubes or CNTs with jagged walls. The presence of 
variability in cells adhering to the device also was a potential issue that was identified. With respect to 
cell growth, a number of parameters need to be understood such as the ideal CNT height for transfection 
and cell growth, use of membranes with different pore spacing or diameters as the CVD template to study 
cell growth when CNT diameters and CNT spacing changes.  
The effect of time and cell growth is also not documented in depth for CNT arrays. It was noted by 
Golshadi that an increase in cell culture time prior to transfection would lead to an increase in transfection 
efficiency. An in-depth study to understand the correlation between transfection efficiency and culture 
time can lead to interesting insights about CNT – cell interfacing. It has also been shown that stem cells 
are highly sensitive to their physical surroundings. Therefore, it will be required to understand the effect 
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